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ABSTRACT

Every year many people suffer from severe chronic pulmonary insufficiency.
Problems that can be incurred include the valve becoming stenotic, where it inhibits
antegrade flow, and incompetent, allowing retrograde flow. When either of these
conditions occurs with great severity, it is often necessary for the native valve to be
replaced. There are no acceptable, permanent solutions currently available for a
pulmonary valve replacement. Previous research, based on regurgitant fraction and
transvalvular gradient, has indicated that a fluid diode could possibly serve as a
permanent valve replacement solution. This study investigated the effectiveness of a
diode to reduce the workload of a right ventricle while maintaining a tolerable regurgitant
fraction and transvalvular pressure gradient. Three different diode geometries were
compared to each other and also to a comparable stenosis and a blank annulus. The valve
prototypes were tested in two positions in the mock pulmonary circulatory system
(MPCS), immediately in the right ventricle outflow tract (RVOT) and also 3 cm
downstream, in the pulmonary artery test section. The results of this study indicate that
while all three of the diode designs performed very similarly to each other in each set of
tests, the performance of the diodes varied greatly between the two positions in which
they were tested. The diodes tested in the RVOT significantly reduced regurgitant
fraction (RF), transvalvular gradient (TVG), and ventricular work as compared to the
stenosis. However, the diodes demonstrated no significant reduction in TVG or
ventricular work as compared to the stenosis or the blank annulus when placed within the
pulmonary artery.
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CHAPTER ONE
INTRODUCTION
Valvular heart disease, which occurs when a heart valve fails to function
correctly, is a potentially lethal condition that affects several million people each year.
Either one of the heart’s four valves may develop a narrowing of the valve opening,
which is called mitral, tricuspid, aortic or pulmonic stenosis, depending on which heart
valve is effected. Another condition which may occur is valvular insufficiency, when the
leaflets of the valve fail to close properly, allowing regurgitant flow during diastole.
Currently, options for patients with stenosed or incompetent heart valves include
either no treatment, or implantation of bio-prosthetic or mechanical valves. Without
treatment, many of these patients can live somewhat normal adolescent lives. However,
as they reach adulthood, often the heart can not keep up with normal activities, and the
condition can become fatal. Bio-prosthetic valves implants are not ideal because they last
only a decade or two and must then be replaced; they have a tendency to deteriorate even
faster when implanted in younger, pre-adult patients (Bloomfield, 2002). Mechanical
valves have successfully replaced mitral and aortic valves for many years. However, due
to the lower operating pressures of the pulmonary circulation, and the increased tendency
for thrombosis to occur on mechanical heart valves in the pulmonary position (Kawachi
et al., 1991), current mechanical valves which have been developed for use in the left
heart are poorly suited as replacements for pulmonary valves (Ilbawi et al., 1987).
Permanent, effective solutions for pulmonary valve replacements are being
sought. One such device being studied is a non-moving preferred resistance device, or
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fluid diode. The purpose of this study is to determine the effectiveness of a fluid diode at
reducing the work load of a heart with a defective pulmonary valve while controlling
regurgitation with reduced pressure gradient, and to study the effects of small changes in
the geometry on such performance. An existing mock pulmonary circulatory system
(MPCS) from previous research was modified significantly to more accurately match the
hemodynamics of the right ventricle and pulmonary artery and to allow for the collection
of instantaneous pressure-volume measurements within the ventricle. The study herein
couples flow visualization with parametric geometry variation to assess the operational
performance of a particular type of diode for use as a pulmonary valve.

Literature Review
The heart is the driving mechanism for the circulatory system. It consists of a
right and left atrium and a right and left ventricle and operates as two pumps in series.
The right atrium is a holding chamber for the right ventricle, which powers the
pulmonary circulation. Similarly, the left atrium is a holding chamber for the left
ventricle, which powers the systemic circulation. During systole, the right ventricle
contracts, driving blood through the pulmonary artery, through the lungs, and into the left
atrium. Simultaneously, the left ventricle contracts, pumping freshly oxygenated blood
throughout the rest of the body and into the right atrium. During diastole, as the ventricles
relax, the atriums contract slightly and blood flows from them into the respective
ventricles, filling them for the next cycle. There are four valves in the heart which
facilitate the forward flow of blood. The mitral and tricuspid valves are between the
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atrium and ventricle of the left and right heart respectively. The aortic and pulmonary
valves are between the left ventricle and aorta and between the right ventricle and
pulmonary artery respectively.
When the heart and all its valves are functioning properly, the cardiac output of
both ventricles is the same, about 5-25 L/min, depending on whether the subject is at rest
or engaged in heavy exercise (Levick, 1995). The average frequency of the heart is 70
beat per minute, also dependent on whether the subject is at rest or exercising (Berne et
al., 1992). In a typical heart beat, which lasts about 850 ms, systole begins when the
aortic and pulmonary valves open, and lasts about one third of the cycle (Yoganathan et
al., 2004).
While the flow rates in each ventricle must remain the same, the working
pressures of the two are quite different. The pulmonary and tricuspid valves of the right
heart typically only experience 30 mmHg of pressure gradient across their leaflets, while
the aortic and mitral valves of the left heart must withstand 100 mmHg and 150 mmHg
respectively (Yoganathan et al., 2004). These widely contrasted pressures in the two
ventricles are due to the fact that the resistance in the peripheral vessel network of the
systemic circulation is approximately ten times the resistance of the pulmonary vessel
network (Berne et al., 1992). This resistance that the pulmonary circulation offers the
right ventricle is best characterized by the pulmonary vascular resistance (PVR) which is
the ratio of the mean pulmonary artery pressure to the mean cardiac output (Weinberg et
al., 2004). Mousseaux et al. (1999) found that normal lungs have a PVR between 1 and 5
mmHg/Lpm, with an average of 2.0 mmHg/Lpm. However, patients suffering from
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pulmonary hypertension could have a PVR over 20 mmHg/Lpm. Another parameter that
greatly affects pulmonary hemodynamics is arterial compliance. As the heart contracts,
the increase in pressure causes the arteries to expand. Consequently, as the pressure drops
during diastole, the arteries revert to their original state. Pulmonary vascular compliance
(PVC) is this change in volume due to the changes in pressures. PVC is characterized by
the ratio of the ventricle stroke volume to the arterial pulse pressure. In a study with 35
subjects, Reuben (1971) found that normal patients had an average PVC of about 2.87
ml/mmHg while the PVC of patients suffering from severe pulmonary hypertension
could be as low as 0.7 ml/mmHg. However, another study reported values ranging from 4
to 8 ml/mmHg (Slife et al., 1990). Both PVR and PVC vary considerably with activity,
and they maintain an inverse relationship (Lankhaar et al., 2008).
There are several congenital and acquired complications that can affect a native
heart valve. The two means of failure that are of primary concern in this study are
stenosis and regurgitation. Pulmonary stenosis occurs when the pulmonary valve is
malformed such that it inhibits forward flow. With a narrow opening, the valve becomes
an orifice, creating a pressure gradient across the valve. This increase in pressure causes
the ventricle to have to work much harder to maintain a healthy cardiac output. Since the
right ventricle can tolerate a mild pressure gradient, a mild stenosis can be ignored. A
pulmonary stenosis is considered to be severe if it causes a pressure gradient of 40 mmHg
or greater (Alexander, 1998). In the medical field, the term pressure gradient simply
refers to the maximum pressure drop across the valve during systole. Often, the leaflets of
a stenosed valve fail to close properly, allowing the flow to regurgitate. This is known as
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an insufficiency. If the regurgitant flow is severe enough, it will significantly increase the
work load on the ventricle and cause the ventricle to dilate. Pulmonary regurgitant flow
of 10-30 mL per stroke is considered mild (Tulevski et al., 2003). Therefore, for a typical
heart rate of 70 beats per minute and a cardiac output of 5 L/min, any pulmonary
regurgitation up to 2.1 L/min, or a regurgitant fraction (RF) of 42%, is considered mild.
If either stenosis or insufficiency is severe enough, the valve may need to be replaced.
Currently, the two options for heart valve replacement are bio-prosthetic and
mechanical valves. The four types of bioprosthetic valves, the stented procine valve,
stented pericardial valve, stentless porcine valve, and homographs have been extensively
review by Butany et al. (2003). While these valves function very similarly to the native
valve, they lack robustness and longevity. Over time these valves can deteriorate and
require additional operations, especially when implanted into younger patients (Fukada et
al., 1997). Despite these shortcomings, bioprosthetic valves are the most common
replacement for pulmonary valves. There are three types of mechanical valves: caged
ball, tilting disk, and bileaflet. Butany et al. produced an extensive review of these valves
as well (2003). All of these valves are susceptible to severe problems such as
thromboembolic complications, pannus formation, and mechanical failure. As blood
flows through a mechanical valve, platelets are disturbed and activated (Harker et al.,
1970). These platelets can begin to coagulate and cause thrombus formations to build up
on the valve. As the formations continue to grow, they can eventually impede the motion
of the valve completely, resulting in valve failure. There is also a risk of
thromboembolism, which occurs when a loose piece of thrombus travels downstream and
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clogs a blood vessel. To minimize the risk of thrombosis, patients who undergo
mechanical heart valve implants must go on anticoagulant therapy. This leads to other
medical issues such as the risk of severe, life-threatening hemorrhaging, especially from
internal wounds. Deviri et al. (1991) found that almost half of the patients in a study who
had a mechanical valve obstructed by thrombus also experienced pannus growth. The
bileaflet valve was less-susceptible to obstructions than the tilting disk valve, and these
obstructions were just as likely to form on an aortic as on a mitral valve. Pannus is the
overgrowth of tissue around the sewing ring and can lead to stenosis and seized leaflets.
Mechanical failure is another possible failure mode for mechanical valves. Early models
such as the caged ball valves were especial susceptible to failure by the balls swelling or
cracking (Butany et al., 2003). While other mechanical valves are susceptible to leaflet
cracking or dislodgement, the occurrences of such failures are much rarer, especially for
bileaflet valves. Two independent follow-up studies conducted by Chang et al. (2001)
and Emery et al. (2003) investigated over 900 recipients of a St. Jude Medical bileaflet
valve and found zero mechanical failures.
With proper anticoagulation therapy, the risk of thromboembolic complications is
greatly reduced for mechanical valves placed in the aortic or mitral positions. However,
due to the lower operating pressures of the right ventricle, mechanical valves in the
pulmonary position are much more prone to thrombosis and pannus growth, even with
appropriate anticoagulant therapy (Ilbawi et al., 1987). Another concern with placement
of mechanical valves in the pulmonary position is mechanical malfunction such as leaflet
flutter and failure to close properly. Gohean et al. (2006) found that the lower vascular
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resistance in the pulmonary circulation can cause aberrant behavior for both bileaflet and
tilting disk valves.
Over the last several years some research has shifted toward the development of
percutaneous pulmonary valve implantation (PPVI). With PPVI, valves, which are
typically homographs, porcine aortic valves, or bovine jugular venous veins, can be
mounted on a stent and inserted in place without the need of open-heart surgery (Lurz et
al., 2008). Not all patients are suitable for percutaneous pulmonary valve insertion. Due
to limitations on the size of these stented valves, patients must meet artery dimension
requirements (Lurz et al., 2009). If the patient’s artery has too large a diameter (larger
than 22 mm), the device can not be dilated enough to fill the entire vessel, and blood
could flow around the stent. Another concern with PPVI is that the stent on which the
valve is mounted has a tendency to fracture. In a study of 123 patients, Nordmeyer et al.
(2007) found that over 20% of the patients developed a stent fracture within three years
of PPVI. In many cases, the fractured stent led to restenosis of the valve, and in one case,
separation of fragments and embolization.
Clearly neither bioprosthetic nor mechanical valves are ideal candidates for
pulmonary valve replacement. Camp et al. (2007) proposed the concept of a fluid diode
as a motionless device to regulate the pulmonary insufficiency. The device, called a fluid
diode, offers significantly more resistance to retrograde flow than to antegrade flow. The
original design, discussed by Losaw (2004), was inspired by a simple nozzle profile as
outlined in the ASME nozzle design manual (Bean, 1971) and the valvular conduit
patented by Tesla (1920). The standard nozzle is shown in Figure 1.1.
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Figure 1.1: Standard nozzle.
Tesla’s valvular conduit seen in Figure 1.2 utilizes a series of backflow passages to
significantly impede reverse flow while the forward flow is less affected. Forward flow in
Figure 1.2 is right to left.

Figure 1.2: Figure 1 from Tesla’s valvular conduit (Tesla, 1920).
This idea is carried forward into the diode discussed by Camp et al. (2007). The nozzle
allows low resistance flow between the ventricle and the artery during systole, but flow
passages increase resistance during retrograde flow of diastole. The resulting diode
design is seen in Figure 1.3. Forward flow is from left to right.
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Figure 1.3: Generically dimensioned diode valve (Camp, 2007).
α - impingement angle of backflow channel jet
d – minor orifice diameter
D – major orifice diameter
β - ratio of minor to major orifice diameter, d/D
L – overall length of the diode
b – minor width of backflow channel
B – Major width of backflow channel
c – annular ring width
The design tested by Camp et al. (2007) used a 25 mm tissue annulus diameter. The ratio
of inlet diameter D to the minor throat diameter d was 2 to 1 or a beta ratio, b, of 0.5.

β =d/D

(1.1)

Camp (2009) continued the development of the diode by investigating various geometry
parameters. An additional design was added which removed the backchannel, resulting in
an open-cusped diode. Figure 1.4 shows two SolidWorks models, one with the
backchannel, and one without the backchannel.
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Figure 1.4: Solidworks models of (a) a diode valve with an enclosed backchannel
(backchannel diode); (b) diode valve with an open backchannel (open cusped diode)
(Camp, 2009).
Several variations of both the backchannel and open cusp diodes were produced, varying
both β and α.
The diodes were tested in vitro in a mock pulmonary circulatory system (MPCS)
and compared based on regurgitate fractions and transvalvular gradients. One design was
tested in vivo in a pig. The in vitro results indicated acceptable levels of regurgitate
fraction and pressure gradients for normal levels of PVR. The results of the diode tested
in vivo were consistent in both tendency and magnitude with the in vitro findings (Camp,
2009).
Both in vitro and in vivo testing of fluid diodes are necessary for the development
of new heart valves. In vitro testing requires a system that closely mimics the conditions
found in a patient. Many mock systems have been developed to study heart valves, but
the system of Camp (2009) will be presented here as it was the baseline for the MPCS in
this study. Figure 1.5 shows a schematic of Camp’s system.
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Figure 1.5: Schematic of the mock circulatory system. Arrows indicate flow direction.
1. Right atrium constant head tank; 2. Right ventricular chamber; 3. Flow meter; 4. Test
section 5; Mechanical heart valve; 6. Ball valves; 7. Capacitance chambers; 8. Holding
tank; 9. Recirculating pump; 10. Pneumatic cylinder; 11. Harvard Pulsatile pump; 12.
Left atrium constant head tank (Camp, 2009)
The blood analog starts in a constant-head tank, which models the right atrium,
and flows into the right ventricle. The ventricle consists of a balloon enclosed in a
chamber. The chamber is cyclically pressurized by a pneumatic cylinder driven by a camdriven pump (Harvard 1423 Pulsatile pump). The pump is adjustable, allowing the
manipulation of heart rate, stroke volume and systolic ratio. The analog then flows
through the test section, which is made of acrylic and houses the test valve. A contraction
reduces the diameter from 62 mm to 25 mm, which is the size of the prototype valves
being studied. The distal section models the human pulmonary artery. Ball valves and
windkessel chambers located downstream of the artery provide adjustable resistance and
compliance elements respectively. The left atrium is another constant-head tank and is
also used to adjust resistance. After flowing through the test section and into the left
atrium, the analog drains into a holding tank where it is then pumped up into the right
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atrium. This system has one flow probe, located upstream of the valve, and two pressure
taps, located just on either side of the pulmonary valve. These allow for instantaneous
pressure and flow measurements to be made, but do not allow for ventricular volume
calculations. In this study, the ventricle is modified both to improve the ventricular signal
and to reduce flow inertance.
A stenotic or incompetent pulmonary valve causes the ventricle to have to work
much harder to produce a healthy cardiac output. Fluid diodes have been studied based
on their ability to regulate regurgitant fraction and transvalvular pressure gradients, which
directly impact the work load on the ventricle. This study is the first to assess the
ventricular work load of fluid diodes. Ventricular response is characterized by a pressurevolume loop, or PVL. According to the Frank Starling Law, the heart responds to a
change in venous return pressure by adjusting its stroke volume such that the end-systolic
volume satisfies the end-systolic pressure-volume relationship (ESPVR). Therefore, by
systematically altering the venous pressure for sequential heart beats, a family of
pressure-volume loops can be obtained to characterize this response. As illustrated in
Figure 1.6, these PVLs define two characteristic curves, the end-systolic pressure-volume
relationship (ESPVR) and the end-diastolic pressure-volume relationship (EDPVR)
(Burkhoff et al., 2005).
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Figure 1.6: Family of PVLs and resulting characteristic curves produced by reducing
ventricular preload (Burkhoff, 2005).
Traditionally, it had been difficult to obtain instantaneous volume measurements, making
progress in these studies slow. Over the last few decades, however, techniques and
devices have been developed to make volume measurements. McKay et al. (1984)
investigated the use of impedance catheters to measure volume. This technique was
successful in measuring changes in stroke volume, but could not indicate absolute
volume measurements. Kass et al. (1986) used conductance catheters to successfully
measure ventricle volume and produced clinical PVLs for anesthetized dogs.
Unfortunately, conductance catheters are quite invasive and therefore not ideal for use in
human patients. Very recently, Baker (2011) has acquired pressure-volume
measurements in human patients. A resulting family of PVLs is shown in Figure 1.7.
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Figure 1.7: Pressure-volume loops obtained clinically (Baker, 2011)
The ESPVR and EDPVR are the result of a natural ventricle adjusting its stroke
volume in response to a change in ventricular preload or afterload. The area contained in
the PVL is equivalent to the external work per beat (Westerhof et al., 2005). The product
of ventricular pressure and flow yields external power, or work per unit time. External
energy is found by integrating the power over a heart cycle. Dividing this energy by the
period of a heart cycle yields average power.

Scope of this Study
(1) Previous studies at Clemson University have measured pressure and flow
during diode testing, and particle image velocimetry (PIV) analysis has been done in the
pulmonary artery test section just downstream of the diode (Camp, 2009). However, no
clear picture of what exactly takes place within the diode has been presented. Therefore a
specific aim of this study is to conduct a two-dimensional flow visualization study of
various diode geometries under pulsatile flow conditions. (2) The second specific aim of
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this study is to study three diode designs in vitro and compare them to a comparable
stenosis and also a blank annulus. It is the hypothesis of this study that PVLs produced
from in vitro testing of various diodes will clearly illustrate a significant reduction in
ventricular work as compared to a stenosed or absent valve case. And so the original
ventricle is redesigned to accommodate collection of pressure-volume data, and PVLs for
the various valve scenarios are obtained for various physiological conditions.
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CHAPTER TWO
FLOW VISUALIZATION TEST SECTION AND METHODS
In theory, the diode reduces retrograde flow by redirecting flow and creating a
vena contracta. It was of interest to see exactly how the diode works in practice;
therefore a flow visualization was conducted on several two-dimensional diodes of
slightly varying geometries. The flow visualization allowed the effects of the diodes
during both systole and diastole to be observed. The two-dimensional test system simply
provides a pulsatile flow condition similar to that experienced by a native pulmonary
valve, while also providing optical access.

2-D Diodes
The diode shapes used in the flow visualization were produced in SolidWorks by
extruding a section view of an existing diode design and then machined from Delrin.
These diodes are defined by the dimensions shown in Figure 2.1.

d

D

Figure 2.1: Generically dimensioned diode for 2-D testing.
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In Figure 2.1, D is the outer diameter, d is the inner diameter at the cusp, and α is the
angle of impingement. α is defined as the angle between the centerline of the diode and a
line that could be drawn from the centerline and tangent to the ellipse of the cusp, at the
very tip. The value d/D is the beta ratio, β. The three diodes produced for this study are
shown in Figure 2.2. All three have a beta ratio of 0.5, but the angle α varies as 60°, 75°
and 90° from left to right. A fourth geometry was tested by placing a vertical glass rod in
the center of each open cusp to form a backchannel in the 75° diode.

Figure 2.2: Examples of one side of the 2-D diodes with varying angles of impingement.

2-D Test Section
A 2-D test section was used in this study to visually observe the effects of the
fluid diodes in a pulsatile flow environment similar to the pulmonary circulation. A full
lumped parameter model was not necessary for this flow visualization because the
emphasis of this portion of the study is concerned with the pulsatility of the pulmonary
circulation. Therefore resistance and compliance elements were not included. The test
section (seen in Figure 2.3) was machined from a 24”x8”x1” piece of Delrin, and
fashioned so that the diodes could be easily interchanged. A clear acrylic sheet was
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bolted on the top and bottom of the test section, forming a sealed chamber. The top sheet
was drilled, tapped, and fitted with 1” hose barbs on either end so fluid could be pumped
in and out of the chamber. Systolic flow is left to right.

RV

PA

Figure 2.3: 2-D test section and interchangeable diodes used for flow visualization.
The transition from the right ventricle (RV) to the diode was a smooth contour, and on
the other side of the diode, a long channel modeled the pulmonary artery (PA). The test
setup is shown in Figure 2.4, which shows the pump, test section, and reservoir.

Figure 2.4: 2-D flow visualization test setup (optics and camera not shown).
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The flow was driven into the “ventricle” section by a cam driven pump (Harvard 1423
Pulsatile pump) capable of a stroke volume up to 100 cc/stroke and a frequency up to 100
cycles/minute. The output phase ratio of systole to diastole also is adjustable within the
pump. During diastole, the pump fills with fluid from both the test section and the
reservoir, thus creating a pulsatile flow in the test section. Through a series of mirrors and
other optics, a laser sheet was brought into the test section from each side of the test
section. This illuminated the 50μm polyamid seeding particles (PSP) within a thin layer
of the fluid through the middle of the chamber. The density of the PSP is 1.03 g/cm3. A
Samsung HD digital camcorder was used to record the motion of the illuminated particles
at 30 frames/sec. The shutter speed was long enough for the moving illuminated PSP
particles to appear as streaks in the individual frames. Each frame was then extracted
from the video and observed to determine exactly what occurs during a cycle.
The Stokes number, which is a dimensionless number which characterizes a
particle’s flow in a fluid, is given by

St =

τV
D

(2.1)

where t is the relaxation time, or particle response time; V is the fluid velocity; and D is
a characteristic length scale in the fluid flow. The relaxation time is found as

τ=

d p2 ρ p
18μ

(2.2)

where dp and rp are the particle diameter and density respectively, and m is the dynamic
viscosity of the fluid. In this flow visualization, with water as the working fluid, a stroke
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volume of 100 cc/stroke, and a pulse rate of 70 bpm, the average Stokes number was
found to be 0.00106. Since 0.00106 << 1, it can be said that the seeding particles used in
the flow visualization do indeed follow the streamlines in the fluid flow, and therefore the
streaks in the images illustrate the streamlines in the flow.

Parameter Matching
The purpose of the flow visualization is to observe what effect a fluid diode
would have in the place of a pulmonary valve. It is therefore important that the
parameters of the tests observed be comparable to those of the human pulmonary
circulation system. In this case, the parameters to be matched are those of the mock
pulmonary circulatory system (MPCS). In the MPCS, the annulus of the pulmonary
artery (PA) has a 25 mm diameter. However, to enhance the flow visualization, the 2-D
test section was doubled in size so that the width of the PA was 50 mm. The height
remained as 25 mm because that was sufficient to maintain a proper 2-D flow through the
middle of the test section where the laser sheet passed through. Due to the increase in size
of the test section, the heart rate and stroke volume also had to be increased. A pulsatile
flow is defined by two dimensionless parameters: Reynolds number (Re) and Womersley
number (α). The Reynolds number is the ratio of inertia forces to viscous forces on a fluid
element (Mott, 2006) and is defined as
Re =

VD
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ν

(2.3)

where V is velocity, D is characteristic length (or hydraulic diameter for this study), and
ν is kinematic viscosity. The Womersley number, defined in Equation 2.4, describes the

pulsatility of a flow and how fully a flow profile can develop between oscillations
(Womersley, 1955).
1

⎛ω ⎞2
α = R⎜ ⎟
⎝ν ⎠

In Equation 2.4 R =

(2.4)

D
and is the radius of the blood vessel, w is frequency, and ν is
2

kinematic viscosity.
Typical Reynolds and Womersley numbers produced for in vitro testing in the
MPCS are 1314 and 20 respectively. Those are the values while operating the MPCS at a
heart rate of 75 bpm and a cardiac output of 5.0 Lpm, and using a blood analogue
solution with a kinematic viscosity (ν) of 3.18 mm2/s. To match these parameters in the
2-D test section for the flow visualization, the required stroke volume and heart rate are
158 cc/stroke and 42 bpm respectively. Unfortunately the available pump is limited to a
maximum of 100 cc/stroke. For convenience, flow visualization was conducted for the
four diodes simply using water as the working fluid, a heart rate of 70 bpm, and a stroke
volume of 100 cc/stoke. While the pulsatile conditions produced in these tests do not
perfectly match the conditions found in the MPCS, they are sufficient to demonstrate how
the diodes performed under pulsatile conditions. More tests were done with one of the
diodes with a blood-analog solution as the working fluid, and the stroke volume and heart
rate were varied to determine if the diodes performed similarly over a broad range of

21

Reynolds and Womersley numbers. The 75° diode was tested with a water-glycerin
solution having a kinematic viscosity of 3.20 mm2/s. The system was operated first with a
stroke volume of 100 cc/stroke and a heart rate of 57 bpm. With that setup, the Reynolds
number was brought down to 1116 and the Womersley number to 23. These numbers
match those of the MPCS within 15%. Then the heart rate was raised to 67 bpm, which
brought the Reynolds number to 1312 (a near perfect match) while the Womersley
number rose only to 25. These tests were performed to illustrate the validity of the all the
flow visualizations done on all the diodes as pertaining to a broad range of pulsatile
flows, including the range of Reynolds and Womersley numbers found in the MPCS used
for in vitro testing of the diodes later in this study.
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CHAPTER THREE
IN VITRO TEST SECTION AND METHODS

The flow visualizations in this study explored the effectiveness of the diode
design to have a preferential flow direction having lower resistance. Previous literature
has indicated that the diode can produce acceptable levels of transvalvular gradients and
regurgitant fractions. This study is interested in assessing the diode’s ability to reduce the
ventricular work load of a heart with a stenosed pulmonary valve. To do so, three diodes
of varying geometries were designed and machined to be tested against a stenosis with
the same b ratio. Several modifications were made to an existing mock pulmonary
circulatory system (MPCS) to create a more physiological environment to test the diodes
in, and to allow the collection of total, instantaneous flow into the ventricle. This chapter
details the design of the diodes and MPCS as well as the methods for calibration, data
collection, and data processing.

Diode Design
Based primarily on previous graduate and undergraduate diode studies conducted
at Clemson University, three parametric variations of a fluid diode were designed and
produced for assessment in this study. Camp’s (2009) results indicated that a beta ratio of
0.5 had a significantly more tolerable TVG than smaller beta ratios. Culbreath (2004)
observed that a beta ratio of 0.5 had one of the highest ratios of reverse flow pressure
drop to forward flow pressure drops in steady flow studies. Therefore all three of the new
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diodes were designed with a beta ratio of 0.5. The entrance nozzle of the diode is
prescribed by exactly one quadrant of an ellipse. This ensures a zero angle of
impingement for forward flow and thus eliminates any vena contracta during systole.
The three new designs are show in Figure 3.1. The ellipse that defines the entrance nozzle
is the same for all three, but the ellipse that defines the cusp is of varying dimensions so
as to accomplish the appropriate angle of impingement.

Figure 3.1: Section views of the three new diode designs for current study. Dimensions
are in mm; systolic flow is left to right.
The three diodes which were machined from stainless steel to the specifications in Figure
3.1 are pictured in Figure 3.2.
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Figure 3.2: Diodes, from left to right: 60°, 75°, and 90°a.
These diodes were tested against a stenosis with similar outer and inner diameters and
thickness. The 0.5b stenosis, machined out of delrin is shown in Figure 3.3.

Figure 3.3: A stenosis with 0.5b ratio.

Mock Pulmonary Circulatory System
The in vitro testing of the diodes was conducted in a mock pulmonary circulatory
system (MPCS). The basis of the system is the lumped parameter network model shown
in Figure 3.4. A schematic of the system is shown in Figure 3.5. The values for
resistance, inertance, and compliance in Figure 3.4 are listed in Table 3.1.
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Figure 3.4: Lumped parameter network model for MPCS.

Figure 3.5: Schematic of MPCS used in this study. The arrows indicate flow direction. 1.
Upstream head tank; 2. Right atrium; 3. Pressure regulator and vent; 4. Diaphragm; 5.
Right ventricle; 6. Pulmonary artery; 7. Flowmeters; 8. Downstream compliance
elements; 9. Downstream head tank; 10. Downstream resistance elements; 11. Holding
tank; 12. Recirculating pump
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Table 3.1: Values for resistance, inertance, and compliance in Figure 3.4
Resistance
(mmHg/Lpm)

Inertance
(mmHg·s/ml)

Compliance
(ml/mmHg)

R1

0.120

L1

0.00367

C1

1.16

R2

0.160

L2

0.00550

C2

1.16

R3

0.143

R4

0.158

R5

0 to 4.5

In Table 3.1, R1 and R2 were measured, R5 was varied 0 to approximately 4.5 throughout
testing, and all other values were calculated.
This system is a modification of a system described by Camp et al. (2007). It
contains open air atrial chambers, a programmable, pneumatically driven ventricle, and
compliance and resistance elements. It allows for pressure measurements to be obtained
in the ventricle and pulmonary artery, and for flow measurements to be obtained from
two flow probes, one downstream and one upstream of the ventricle. The flow probe
arrangement allows for instantaneous flow measurements and the ability to measure
instant stroke volume.
A photograph of the MPCS on the lab table is seen in Figure 3.6. The system is
more compact than its predecessor (Camp et al., 2007), reducing both the influence of
inertance and the fluid volume used. Further, the pneumatic regulator offers a wider
range of heart rate.
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Figure 3.6: Photograph of the MPCS used in this study.

Figure 3.7: Constant-head tank.
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The upstream head tank (Figure 3.7) was a 150 mm acrylic tube, closed off on the
bottom by a delrin cap. An overflow connection in the tank ensured a constant fluid level,
even during the system’s pulsatile operation. This tank provided an adjustable constant
pressure head for the right atrium.
The original system had a hose connecting the upstream head tank directly to the
ventricle. However, to reduce inertance of the fluid upstream of the ventricle, a compliant
component was added to function as the right atrium. This was provided by a latex
balloon as shown in Figure 3.8.

Figure 3.8: Right atrium, which consists of a latex balloon.
Also seen in Figure 3.8 is the upstream flow probe, which monitors the flow through the
tricuspid valve. This upstream probe is a Carolina Medical Electronics P6100
electromagnetic flow probe with a 32 mm nominal inside diameter. The tricuspid valve
was a SJM bileaflet valve placed in the fitting at the entrance to the ventricle.
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The ventricle itself (see Figure 3.9) was a novel design in which power is
provided by a pneumatically driven rubber-silicone diaphragm. The ventricle consisted of
two chambers bolted together, one for air and one for fluid, separated by this diaphragm.
The fluid chamber had a contraction that reduced the ventricle diameter from 127 mm to
25 mm, the size of the diodes tested in this study. The contraction dimensions were
similar to those used by previous Clemson researchers, originally taken from a work by
Figliola (1976). The contour profile was, however, converted to a series of arcs, for the
benefit of the machinist, and scaled up to accommodate the larger dimensions of the new
ventricle.

To Pressure
Regulator

Outlet

To Vent

Inlet

Diaphragm separating
air and fluid chambers

Pressure taps, located
on every side

Figure 3.9: Drawing of the right ventricle used in this study.
The fluid chamber of the ventricle was made of clear, polished acrylic. The inlet
hole in the fluid chamber was drilled at a 30° angle so that a laser sheet could be brought
in through the center of the test section if flow visualization or particle image velocimetry
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(PIV) is desired in the future. The downstream side of the ventricle was designed to allow
the placement of a flow probe and then tie into the existing pulmonary artery test section
used in previous Clemson research.
The pressure wave that drives the diaphragm was shaped by a Hoerbiger variable
pressure regulator (Tecno Basic PRE-U series) to create a more physiological systolic
signal. While the Hoerbiger provides some venting at the start of diastole, adding an
additional 3way flow control valve (MAC, Inc; ISO 3 series) allows the air chamber to
vent more quickly, enabling the ventricle to fill properly during diastole. Both the
pressure regulator and the vent are controlled by a National InstrumentsTM LabVIEWTM
DAQ system. Figure 3.10 is part of a screenshot from the LabVIEW VI that controls the
ventricular drive pressure.

Figure 3.10: Waveform of signal to Hoerbinger and TTL signal to MAC valve.
The waveform sent to the Hoerbinger regulator is labeled “Wave” in Figure 3.10. The
following function controls the waveform
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F ( A, f , t ) = A

sin (πft )
⎛ ft ⎞
1+ ⎜
⎟
⎝ 0.47 ⎠
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(3.1)

where A is amplitude in volts, f is frequency in Hertz, and t is time in seconds. The
function operates very similarly to a simple sine function with an amplitude of A for the
first 47% of the cycle. At that point, the term in the denominator rapidly increases in
magnitude, driving the function to a near-zero value very quickly. The value of 0.47 was
chosen by a trial and error, operating the MPCS with the SJMB valve until the pressure
and flow traces indicated a systolic ratio of about 35%. The two parameters of this
waveform function which can be changed are frequency and amplitude. The frequency
was held at 1.25 Hz throughout the entire study, producing a heart rate of 75 bpm. The
amplitude controls the ventricle stroke volume and was adjusted with each MCPS setting
so that the cardiac output was maintained at a constant level. The TTL signal, or square
wave, in Figure 3.10 controlled the venting MAC valve. The valve would close when the
signal was high, and open, or vent, when the signal was low. The two adjustments which
could be made to the vent signal were its duty cycle, or duration, and its phase. Both the
duty cycle and phase were held constant throughout this study.
The diodes tested fit snugly into the inlet of the pulmonary artery test section.
This section was also made of clear, polished acrylic for optical access. The pulmonary
artery used (Figure 3.11) is described by Camp (2009). Its only modifications were that
the outflow hose barbs were enlarged to reduce resistance. Resistance in the right branch
was reduced to 0.12 mmHg/Lpm, and resistance in the left branch was reduced to 0.16
mmHg/Lpm.
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Figure 3.11: Pulmonary artery test section used in this study. Dimension in mm.
Vascular compliance in the system was provided by two Windkessel chambers
(Figure 3.12). These were constructed from 100 mm diameter PVC pipes and were 600
mm tall. The bottom ends were capped and had hose barb fittings installed. The top ends
are sealed with pneumatic plumber plugs which can be placed at any height in the
chamber. As the pressures in the system rises during systole, the air in these chambers
gets compressed, and the volume is reduced. This change in volume in response to a
change in pressure provides a compliance element for the system. Adjusting the height of
the plugs varies the initial volume of trapped air in the chamber and thus provides a
means of adjusting the system compliance.
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Figure 3.12: Windkessel chamber.
Vascular resistance is added to the system by means of a squeeze clamp on the
tubing downstream of the Windkessel chambers (Figure 3.13). There were also ball
valves immediately downstream of the Windkessel chambers that were used to balance
the flow between the two artery branches. These valves were not used to regulate
vascular resistance due to their non-linearity and the imprecision to provide for
systematic, minute adjustment. While the squeeze clamp used in this study was also nonlinear, it was preferable to the ball valves because the distance between the top and
bottom of the clamp could be measured with a caliper, and therefore resistance settings
could be systematically replicated from one experiment to the next. The actual resistance
of the squeeze clamp was not measured or set for data collection, but rather the clamp
was adjusted iteratively until the desired pulmonary vascular resistance (PVR) was
achieved. PVR was determined by processing the data after each set was collected.
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The constant-head tank downstream of the resistance element modeled the left
atrium. It was constructed exactly like the one for the right atrium and could be raised
and lowered to set the left atrium pressure at the desired level.

Figure 3.13: Hose clamp used as a resistance element.
Flow exiting the left atrium through the overflow pipe drained into the holding tank
where the centrifugal pump could then pump it back up into the right atrium.

Flow, Pressure, and Volume Measurements
The hemodynamics of the MPCS are characterized by the pressures and flows in
the ventricle and artery test sections during a heart cycle. The work load on the ventricle
is characterized by the instantaneous ventricular volume and pressure during a heart
cycle. Measuring both ventricle and arterial pressures and flow both upstream and
downstream of the ventricle provided all the necessary information to parametrically
evaluate the diodes in this study. All data was acquired using a National InstrumentsTM
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automated data acquisition (DAQ) system (NI PCI-6052E card and SCB-68 connection
box) and 2008 LabVIEWTM8.5 software. Post-processing of data was done using
MATLAB®.
Instantaneous and mean flow data immediately upstream and downstream of the
ventricle were measured using two flow probes (Carolina Med., P680 and P6100 series)
(shown in Figure 3.14) and two Carolina Medical model 501 electromagnetic flowmeter
boxes (shown in Figure 3.15).

Figure 3.14: EP680 and EP6100 electromagnetic flow probes.
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Figure 3.15: FM501 electromagnetic flow meter boxes.

To eliminate signal noise and interference between the two probes, the boxes
were connected to each other with a synchronization cable. This ensured that the probes
operated in phase with each other. The boxes also shared a common system ground, a
stainless steel wire inserted into the ventricle through a spare pressure tap. The flow
probes were calibrated using a catch and weigh technique. Sources of error and
assessment of the uncertainty in the flow measurements are discussed in the Appendix.
Each flow meter box was also zeroed and balanced before each set of tests. During postprocessing of the downstream flow data, a zero crossing algorithm used by previous
Clemson researchers separated the instantaneous flow data into forward (positive values)
and reverse (negative values) flow data. The net forward and reverse flow rates were then
determined by time-averaged numerical integration as
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Q=

1 n (Qi + Qi +1 ) ⋅ (t i +1 − t i )
.
∑
2
Δt i =1

(3.2)

Equation 3.2 was applied to both the forward and reverse flow rates so that the average
forward and reverse flow rates over the whole heart cycle were available. Clinically the
regurgitant fraction is calculated as regurgitant volume over the stroke volume. Since
Qreverse and Qforward are the average flow rates over the whole cycle, they supplement the
regurgitant volume and stroke volume respectively to produce the following equation.
RF [%] =

Qreverse
⋅ 100 .
Q forward

(3.3)

Right ventricular pressure (RVP) and pulmonary artery pressure (PAP) were
measured with BD DTXPlus physiological pressure transducers. Pressure taps were
located in the vertical center of both the ventricle and pulmonary artery. The pressure tap
on the ventricle was a wall tap, simply a hole drilled in the side with a hose barb to
connect a tube from the tap to the pressure transducer. The pressure tap in the artery was
a small hole in the side of a catheter tube run through a fitting downstream, up through
one of the artery branches to the middle of the artery just downstream of the annulus.
Both locations are shown in Figure 3.16. The transducers themselves were located on a
stand fixed to the floor rather than the table in order to minimize noise from system
vibrations (Figure 3.17) and set at the elevation of the center of the test section to define
system zero.
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Figure 3.16: Pressure tap locations in ventricle and artery.

Figure 3.17: BD pressure transducers on isolated stand, at system zero.
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The instantaneous transvalvular pressure gradient (TVG) was found as

TVG[mmHg ] = RVPpeak − PAPpeak .

(3.4)

Pulmonary vascular resistance (PVR) and pulmonary vascular compliance (PVC)
were derived from the system impedance spectrum as defined by
Z (ω ) =

PAP(ω )
Q(ω )

(3.5)

where |PAP(w)| and |Q(w)| are the pressure and flow spectrums obtained by a Fourier
analysis. The zeroth harmonic (Z0) of the impedance modulus defines the PVR of the
system. The PVC of the system is determined by the inverse of the first harmonic (Z1) of
the impedance modulus. The impedance phase can be useful for describing the
compliance and inertance of the system as well.
The upstream and downstream instantaneous flow rates provided the measure of
the instantaneous volume. The upstream and downstream flow rates were added together
with flow into the ventricle considered positive. Then starting with an arbitrary initial
volume, the instantaneous volume over one cycle was found by simple backward
integration of the total flow into the ventricle as

V( i ) = V( i −1) +

(Qtotal ( i −1) + Qtotal ( i ) )Δt
2

(3.6)

where V(i) is the instantaneous ventricular volume at a particular timestep i, and Qtotal is
the total flow into the ventricle. Values for V and Qtotal evaluated at the previous timestep
are denoted by subscript (i-1).
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Ventricular Work
Ventricular work, energy, and power is determined from the instantaneous
ventricular pressure and volume measurements. The external work (W), or energy
production of the ventricle is defined by the integral of instantaneous power, which is the
product of the instantaneous pressure (P(t)) and flow (Q(t))

W = ∫ P(t ) ⋅ Q(t ) ⋅ dt .

(3.7)

It is important to note that Q(t) in Equation 3.7 and 3.8 is the total instantaneous flow of
fluid into the ventricle, which is found by combining the upstream and downstream flow
signals. Since volume is the integral of instantaneous flow, the external ventricular work
can be visualized by the pressure-volume loop (PVL) and is defined by the area enclosed
by the PVL. The average power over a heart beat is found by multiplying the work by the
heart rate frequency, or with T as the heart period, by
P = (1 / T ) ⋅ ∫ P(t ) ⋅ Q(t ) ⋅ dt .

(3.8)

Test Fluids
A nominal 40% by volume glycerin/water solution at 22°C was used for all in
vitro testing in the MPCS. A small amount of sodium chloride (~1 cc/L) was added to
create an electrolytic solution, which is necessary for the electromagnetic flow meters to
function properly. The kinematic viscosity of the blood analogue solution, which was
checked with a Cannon-Fiske U-tube viscometer, was maintained at about 3.25 cSt.
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CHAPTER FOUR
RESULTS AND DISCUSSION

Flow Visualization Results
A parametric flow visualization study was conducted for all four diodes with plain
water, a heart rate of 70 bpm, and a stroke volume of 100 cc/stroke, as previously
discussed in Chapter Two. The 75° diode was also then tested under various pulsatile
conditions closely matching those found in the mock pulmonary circulatory system
(MPCS), based on Reynolds Number (Re) and Womersley Number (α), so that
conclusions could be made of the diodes’ performance over a broad range of pulsatile
conditions.

Systolic Performance
Figure 4.1 shows peak systolic flow photographs for each diode design tested.
The direction of the flow in each image in Figure 4.1 is from left to right. In the figure,
the pictures from left to right are for diodes having apex angles of 60°, 75°, 75° with
backchannel, and 90°, respectively.
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Figure 4.1: Function of all four diodes during systole. From left to right: 60°, 75°, 75°
with backchannel, and 90° diodes. Photo duration is 33.3 ms.
In the tests in which the photographs in Figure 4.1 were taken, the working fluid is water
(ν=0.9634 mm2/s), the stroke volume is 100 cc/stoke, and the heart rate is 70 bpm, which
results in an average Reynolds number of 3178 and a Womersley number of 46.7 in the
pulmonary artery of the 2-D test section. The photographs taken during peak systole
indicate that the diode designs function almost identically to each other during systole.
Each photograph in Figure 4.1 reveals a strong jet through the nozzle entrance with a
little vortex forming inside the cusp on both sides of the diode. The jet fills the entire
width of the diode between the two cusps, and there is no significant flow separation
through the nozzle up to the cusps. Therefore during systole, the antegrade flow is
funneled through the diode and can flow through the entire 25.4mm cross-section. The
similarity of flow in systole between the diode designs is not unexpected given the
identical inflow nozzle profile used for each. One of the concerns with the diode design
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was the possibility for the cusps to produce a small area where blood could stagnate and
promote thrombosis. However, the vortices seen in the photographs in Figure 4.1
effectively “flushed out” the cusps continually during systole so that there were no
stagnant areas. The vortices move downstream as illustrated in the sequence of images in
Figure 4.2 and eventually dissipated. Direction of the flow in Figure 4.2 is left to right.

Figure 4.2: Sequence of images during systole immediately downstream of the cusp of
the 75° diode. Photo duration is 33.3 ms for each image.
Diastolic Performance
Figure 4.3 shows the photographs for each diode under the aforementioned
conditions but during diastole. The direction of the flow in each image in Figure 4.3 is
primarily from right to left. In the figure, the photographs from left to right are for diodes
having apex angles of 60°, 75°, 75° with backchannel, and 90°, respectively.

44

Figure 4.3: Function of all four diodes during diastole. From left to right: 60°, 75°, 75°
with backchannel, and 90° diodes. Photo duration is 33.3 ms.
As seen each photograph in Figure 4.3, there is significant flow separation as the cusp of
the diode redirects the flow from the outside of the artery towards the center of the diode.
This results in a vena contracta that effectively reduces the area that the regurgitant flow
can pass through. The distance between the two cusps of the each diode is 25.4 mm, but
clearly the regurgitant flow can only flow through a reduced portion of this cross-section.
Each of the photographs in Figure 4.3 was imported into AutoCAD and scaled to the
correct size. Then the effective cross-section, which is reduced by the vena contracta was
easily measured. For the diode with the 60° apex angle, the effective flow area is reduced
to 14.9 mm across. For the diode with the 75° apex angle, the effective flow area is
reduced to 13.2 mm across. For the diode with the 75° apex angle and a backchannel, the
effective flow area is reduced to 14.7 mm across, which, while it is a slight improvement
of the 60° diode, it is not an improvement over the 75° diode with no backchannel. For
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the diode with the 90° apex angle, the effective flow area is only reduced to 16.7 mm
across, which gives it the poorest performance of all four of the designs. The 2-D test
section has a depth of 25.4 mm, therefore the 75° diode, which performed the best,
reduced the effective area from 654 mm2 to 335 mm2, a 48% reduction. It is expected that
a diode placed in the MPCS would reduce the effective area during diastole even more
since the vena contracta will have a three-dimensional effect.

Pulsatile Parameter Matching
The photographs in Figures 4.1 and 4.3 provide a comparable analysis between
the varying diode geometries in a pulsatile system; however, the average Reynolds and
Womersley numbers under those testing conditions did not perfectly match those found
under normal operating conditions in the MPCS where the 3-D diode designs are tested.
Therefore the diode with the 75° apex angle, which performed the best in those tests, was
tested again under pulsatile conditions that closely matched those found in the MPCS.
The purpose of these tests was to determine if the 75° diode performs similarly under a
range of Reynolds and Womersley numbers which encompasses those found in the
MPCS. The 75° diode was tested with a water-glycerin fluid having a kinematic viscosity
comparable to blood (ν=3.20 mm2/s). The 2-D system was run with a stroke volume of
100 cc/stroke and a heart rate of 57 bpm, yielding a Reynolds number of 1116 and
Womersley number of 23. This was the setup that matched both Reynolds and
Womersley as close as possible to that of the MPCS, about 15% error for both
parameters. The system was then run with the heart rate raised to 67 bpm, which matched
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the Reynolds number for the MPCS (1314) but raised the Womersley number to 25.
Figure 4.4 below shows the systolic pictures comparing the 75° diode tested in water to
those tested in the water-glycerin mixture. From left to right they are the diode in water
with a heart rate of 70 bpm, in water-glycerin at 57 bpm, and water-glycerin at 67 bpm.
The direction of the flow in each image in Figure 4.4 is from left to right

Figure 4.4: Function of the 75° diode during systole, varying working fluid and heart rate.
From left to right: the diode in water with a heart rate of 70 bpm, in water-glycerin at 57
bpm, and water-glycerin at 67 bpm. Photo duration is 33.3 ms.
The three photographs in Figure 4.4 are nearly identical to each other, and therefore
suggest that the performance of the diode during systole remains the same for the range
of Reynolds and Womersley numbers represented by these tests. The results of
comparing the three setups during diastole are also very similar. Figure 4.5 below shows
the diastolic pictures in the same order as above. The direction of the flow in each image
in Figure 4.5 is primarily from right to left.
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Figure 4.5: Function of the 75° diode during systole, varying working fluid and heart rate.
From left to right: the diode in water with a heart rate of 70 bpm, in water-glycerin at 57
bpm, and water-glycerin at 67 bpm. Photo duration is 33.3 ms.
It is clear that the diode has essentially the same effect in each setup. In all three of the
photographs in Figure 4.5, the cusps of the diode function similarly by redirecting the
retrograde flow towards the center of the diode, creating a vena contracta. It is important
to notice from this comparison is that the diode performed essentially the same across the
range of flows in which it was tested. This confirms that the tests run on the varying
diode geometries in plain water are indeed valid indicators as to how the diode will affect
regurgitant flow in the MPCS.
The flow visualization clearly shows that all of the diodes tested functioned as
they were designed to by reducing the effective area that retrograde flow can pass
through. The typical systolic and diastolic patterns created by the diodes are illustrated in
the drawings below.
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Figure 4.6: Typical systolic (left) and diastolic (right) flow profiles through diode.
The inlet nozzle of each diode funneled the antegrade flow through the diode, creating a
strong jet with vortices on either side of it. The vortices, which originate in the cusps at
the onset of systole, proceed downstream between the jet and the artery walls until the
end of systole. During diastole, the cusp of each diode re-directed the outside flow toward
the center of the channel, creating a vena contracta. This vena contracta reduced the area
through which the fluid could flow. The parametric studies done on the diodes with water
as the working fluid indicate that the diode with the apex angle of 75° provides the
largest flow area reduction with its vena contracta during diastole. This suggests that it
has the best diastolic performance in reducing regurgitant flow.
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MPCS Test Results
A parametric study was conducted with three diode designs, and they were
compared to each other as well as to a comparable stenosis and a blank annulus. Tests
were run with the diodes placed in the right ventricular outflow tract (RVOT) as well as
just downstream of the pulmonary artery annulus. Pressures and flow rates were
measured, and device performance was evaluated based on regurgitant fraction,
transvalvular gradient, and ventricular work. Parametric variations of the diode design
were tested in the MPCS under conditions relevant to human physiology.

Test Conditions
For the parametric in vitro testing in the MPCS, the following conditions were
maintained: cardiac output between 5.00 and 5.20 Lpm, pulse rate of 75 beats per minute
(bpm), and a systolic ratio of about 40%. The pulmonary vascular resistance (PVR) was
varied between 1 and 5 mmHg/Lpm, and the pulmonary vascular compliance (PVC)
which is coupled with PVR, varied between 2 and 5 ml/mmHg. The PVR was varied by
changing the downstream resistance by adjusting the resistance clamp. Cardiac output
was maintained by varying the stroke volume of the ventricle. Stroke volume was found
to be a function of PVR because as the resistance was increased, RF also increased, and
as RF increased, the stroke volume had to be increased to maintain a constant CO.
In this study, the first 25 cycles of each data set were analyzed to determine all of
the results. It was of interest to ensure that having N=25 was sufficient for the results to
be independent of sample size. Several sets of data, from various valve devices and with
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varying PVR, were processed with N=13 and then N=25. The results using the two
sample sizes were then compared to each other. In all of the data sets checked, the peak
and mean pressures varied less than 0.2%, mean flow (CO) varied less than 0.4%, and the
calculated values for PVR, PVC, TVG, RF, and ventricular work varied less than 0.8%.
This indicates that N=25 is indeed a sufficient number of cycles for an analysis.
It was also of interest to determine the consistency of the MPCS over time and
between data sets, or how well the experiments could be controlled. To gain this insight,
the MPCS was run continually, and several sets of data were collected, analyzed, and
compared. This was done for multiple valve devices and for various PVRs. Across the
board, the results of the repeated experiments were very consistent. Between the
consecutively repeated data sets with the same MPCS settings, the pressure
measurements typically differed by less than 2%, and flow measurements by less than
3%. The calculated values for PVR, PVC, TVG, RF, and ventricular work in the
consecutive data sets varied from set to set by less than their 95% confidence level
uncertainties. This indicates that the experiments are well-controlled and that the data and
its results do not vary significantly over time.

System Verification
The MPCS was operated using a St. Jude Medical Bileaflet (SJMB) mechanical
valve to ensure that physiological behavior of pressures and flow rate could be simulated.
Pressure-Volume loops were obtained with the SJMB valve to demonstrate the system’s
capability to determine ventricular work. The MPCS was operated over a range of PVR,
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and the right ventricular pressure (RVP), pulmonary artery pressure (PAP), and flow rate
signals upstream (Qu) and downstream (Qd) of the ventricle were measured. A typical
pressure and flow trace with the SJMB is shown in Figure 4.7. The settings in the MPCS
when this trace was obtained were as follows: CO of 5.10 ± 0.130 Lpm (95%), HR of 75
bpm, PVR of 3.26 ± 0.170 mmHg/Lpm (95%), and PVC of 2.51 ± 0.188 ml/mmHg
(95%). These pressure traces were generally consistent with physiological traces shown
by Rosendorff, (2001) which are shown in Figure 4.8.

Figure 4.7: Physiological signals for the SJMB valve.
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Figure 4.8: Pressure signals in the heart. (Rosendorff, 2001)
During diastole, the flow should be zero. With the SJMB valve however, the trace
hovers slightly below zero due to a small amount of valve leakage. At the onset of
systole, the ventricle pressure rises sharply. When it overcomes the artery pressure, blood
begins to flow downstream through the valve, and the flow trace rises with the ventricle
pressure. As the ventricle pressure peaks, so does the flow, and both fall together as
diastole begins again. The artery pressure, which also rises during systole, displays a
distinct dicrotic notch which occurs as the pulmonary valve closes. This notch coincides
with the sharp negative spike in the flow signal which is caused by leakage as the valve
closes.
The dicrotic notch in the PAP signal is more accentuated than is generally seen in
clinical data, and the wave directly following the notch is unusual. While it can not be
proved, this study attributes this wave to pressure waves reflecting through the noncompliant pulmonary artery test section.
Figure 4.9 is a typical pressure and flow trace for the 0.5b stenosis. The settings
in the MPCS when this trace was obtained were as follows: CO of 5.13 ± 0.150 Lpm
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(95%), HR of 75 bpm, PVR of 2.81 ± 0.168 mmHg/Lpm (95%), and PVC of 2.70 ±
0.0690 ml/mmHg (95%). While the magnitudes of the traces of pressure in Figure 4.9
vary with PVR, the general shape of the signals stay the same; therefore only this one
figure is presented. Throughout the stenosis testing, as the PVR was raised, the amplitude
of the pressure wave driving the ventricle had to be increased in order to maintain a
consistent cardiac output between 5.00 and 5.20 Lpm. As the amplitude of the driving
pressure wave was increased, the systolic pressure in the ventricle also increased. As seen
in Figure 4.9, even for a PVR of 2.81, which is within the normal range for an adult, the
ventricle must produce abnormally high pressures to produce the required output. The
transvalvular gradient is also severe, at 34.0 ± 0.910 mmHg.
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Figure 4.9: Physiological signals for a 0.5b stenosis.
Typical physiological traces for a diode in this MPCS are shown in Figure 4.10.
The traces for all three diodes are very similar to each other; therefore just this trace for
the 60°a diode is presented. The settings in the MPCS when this trace was obtained were
as follows: CO of 5.02 ± 0.210 Lpm (95%), HR of 75 bpm, PVR of 2.78 ± 0.191
mmHg/Lpm (95%), and PVC of 2.53 ± 0.0970 ml/mmHg (95%).
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Figure 4.10: Physiological signals for a 60°a diode.
The shapes of the pressure and flow signals are very similar for the stenosis and diodes.
As seen in Figure 4.10, the diode also creates a higher than normal peak RVP, but the
transvalvular gradient of 27.0 ±1.06 mmHg (95%) is tolerable (Alexander, 1998). Both
the peak RVP and TVG for the diode are an improvement over the stenosis.

Fourier Analysis
A Fourier analysis of the input impedance (given by Equation 3.5) was used to
determine PVR and PVC for a set of data. Clinically, PVR of a pulmonary system is

56

determined by the average PAP divided by the cardiac output, or average flow as shown
in the following equation.
⎡ mmHg ⎤ PAPmean
PVR ⎢
⎥=
CO
⎣ L min ⎦

(4.1)

The zeroth harmonic of a Fourier transform of a signal is the average of that signal.
Therefore, the zeroth harmonic of the impedance modulus gives the value for the average
PAP over the average flow and thereby defines the PVR of the system for that data set.
Weinberg et al. (2004) observed excellent correlation between clinical measurements of
PVR the zeroth harmonic of the impedance modulus. Weinberg also found an inverse
relationship between the first harmonic of the impedance modulus and in vitro testing of
PVC. Clinically, PVC of the pulmonary system is found as

⎡ ml ⎤
CO
PVC ⎢
=
⋅ 1000
⎥
⎣ mmHg ⎦ PAPpulse ⋅ HR

(4.2)

where PAPpulse is the pulse pressure, or difference between the maximum and minimum
PAP pressures. Camp (2009) calculated PVR and PVC using both the clinical and Fourier
analysis methods and found them to be very well correlated. In this study the Fourier
analysis method is used to determine PVR and PVC.
The Fourier analysis was done using the FFT (fast Fourier transform) function in
Matlab®. Twenty five consecutive cycles of data were analyzed for each data set. The
FFT function was applied to the downstream flow and PAP data sets, and the impedance
spectra for those twenty five sets were found by dividing the PAP spectra by the flow
spectra. An ensemble average was then taken of the twenty five impedance spectra to
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produce one impedance spectrum characteristic of the entire data set. The impedance
modulus is the magnitude of the spectrum. Figure 4.11 is a typical plot of the impedance
modulus for the SJMB valve. The MPCS settings for this data set were as follows: CO of
5.10 ± 0.03 Lpm, HR of 75 bpm, and PVR of 3.26 ± 0.17 mmHg/Lpm. Figure 4.11 was
produced by plotting the magnitudes of the harmonics of the impedance spectrum against
their corresponding frequencies. The harmonics of the spectrum are found at multiples of
the fundamental frequency of the data set, which is 1.25 Hz, corresponding to the heart
rate, which was 75 bpm. The impedance phase plot for the same data set is shown in
Figure 4.12. This plot was produced by plotting the phase angles of the harmonics of the
impedance spectrum against their corresponding frequencies.

Figure 4.11: Typical impedance modulus plot for the SJMB valve.
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Figure 4.12: Typical impedance phase plot for the SJMB.
In general, both the impedance modulus and phase plots are consistent with those of a
natural cardiac system as shown by Westerhof et al., (2005). In Figure 4.11 the zeroth
harmonic and inverse of the first harmonic match the PVR and PVC for that data set as
determined by Equations 4.1 and 4.2. Typically the amplitudes of the higher frequency
harmonics can be averaged to determine the characteristic input impedance. However,
due to the 5 Hz filters placed on the pressure data, any component of the impedance
spectrum at a frequency higher than 5 Hz has been attenuated and not reliable. The phase
plot, which starts at zero degrees and immediately drops to a negative value, indicates
that the MPCS is indeed a compliant system.
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Ventricular Work
Ventricular work was extracted from a pressure-volume loop analysis of the
cardiac cycle. The total flow into the ventricle was found by subtracting the downstream
flow through the pulmonary valve (Qd) from the upstream flow through the tricuspid
valve (Qu). The instantaneous volume of blood in the ventricle was then found by
integrating the instantaneous flow of blood into the ventricle. The method of integration
used was a discrete backward trapezoidal integration beginning with the second data
point in the set.
V (t ) = V( t −1) +

1
(Q(t −1) + Q(t ) )Δt
2

(4.3)

The first data point, or the initial volume, was set to 160 ml, which is significantly larger
than a typical human end-diastolic volume. However, it was necessary for the initial
volume to be so large because in some of the tests with a higher system PVR, the stroke
volume required to accomplish the correct cardiac output approached 160 ml. A smaller
initial volume would produce a negative volume in the ventricle towards the end of
systole, and that is not physiologically possible. It is not uncommon for patients with
incompetent pulmonary valves to have a grossly dilated right ventricle.
The pressure-volume loops (PVLs) were obtained by plotting the right ventricular
pressure (RVP) against the instantaneous ventricle volume. Figure 4.13 is a set of PVLs
for the SJMB valve over a range of PVR between 1.79 and 3.56 mmHg/Lpm. PVC
ranged from 2.12 to 4.62 ml/mmHg and CO was maintained between 5.0 and 5.2 Lpm.
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Figure 4.13: Pressure-volume loops for Saint Jude medical bileaflet valve.
In general, the shape of the PVLs in Figure 4.13 are consistent with those of a natural
right ventricle (Baker 2009). The smallest PVL in Figure 4.13 corresponds with the
lowest PVR. As the PVR increases, so does the size of the PVL. Since ventricular work is
defined as the area of the PVL, it is clear that the ventricle responds to an increase in
PVR by working harder in order to maintain a stable CO. As illustrated in Figure 4.13,
the MPCS in this study has the capability to produce PVLs for a valve prototype over a
range of PVR, and from those PVLs, the ventricular work required to produce a
consistent CO can be extracted. The small gap in the PLVs is due to a small error in the
flow measurements that accumulates through the integration process. The ventricle
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volume at the end of a heart cycle should be the same as the initial volume; therefore the
small gap illustrates the uncertainty in the volume calculations.

Results for Valve Types Placed in RVOT
Figure 4.14 illustrates the valve placement for the set of tests with the device
placed in the RVOT. An adapter was used to hold the diode or stenosis between the
contraction of the ventricle and the flow probe.

Figure 4.14: Placement of device in the RVOT.
The 60° and 75° diodes and the 0.5 β stenosis were tested in the MPCS under
various physiological conditions and compared to each other. Throughout all of the
testing, CO was maintained between 5.00 and 5.20 Lpm, and HR was maintained at 75
bpm. Each device was tested multiple times as the MPCS was adjusted to varying levels
of PVR. PVC ranged between 1.78 and 3.20 ml/mmHg. The two diodes and the stenosis
were compared based on the resulting TVG, RF, and ventricular work.
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Figure 4.15: Transvalvular gradient vs. resistance for stenosis, 60° and 75° diodes.
Figure 4.15 is the plot of TVG vs. PVR for both diodes and the stenosis and clearly
shows a distinct difference in TVG between the stenosis and the diodes, but the TVG of
the two diodes are very similar to each other. This was the expected results as both diode
designs had the same nozzle-shaped inlet, and a nozzle should produce a lower TVG than
a stenosis. To further quantify the differences between the three devices, a 2nd order
polynomial regression curve was fit to the data sets using a least-squares regression
analysis so that the stenosis and diodes could be directly compared to each other at
specific values of PVR. The resulting equations and their corresponding standard error of
the fit (sxy) are shown in Table 4.1.
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Table 4.1: Regression curve fits for TVG (y) vs. PVR (x) data sets
2nd Order Polynomial

Valve

sxy (mmHg)

0.5β Stenosis y = 0.9929x2 + 9.1438x + 1.1817

0.498

60°α Diode

y = -0.1491x2 + 11.514x - 4.3223

0.690

75°α Diode

y = -1.3084x2 + 17.128x - 8.5568

0.673

Table 4.2 gives a direct comparison of the TVG at specific PVRs within the tested
range. Values for PVR are listed across the top of the chart, the valve types are listed
along the left side, and the cells in the middle of the table are the corresponding values
for TVG with their 95% confidence interval.
Table 4.2: Direct comparison of TVG (mmHg) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β Stenosis 17.1±1.03 23.4±1.03 30.2±1.03 37.5±1.03 53.6±1.04
60°α Diode

12.6±1.14 18.1±1.15 23.5±1.15 28.9±1.14 39.3±1.14

75°α Diode

12.2±1.13 20.5±1.14 26.1±1.13 31.1±1.13 39.0±1.13

1

mean ± uncertainty (95%)

From the data in Table 4.2, it is clear that the diode created a substantially lower
TVG than the stenosis. At a low PVR of 1.5 mmHg/Lpm, the TVG of the 60° diode was
26.4% lower than the TVG of the stenosis and 11.1% lower than that of the 75° diode. At
a PVR of 3.0 mmHg/Lpm, the TVG of the 60° diode was 23.1% lower than the TVG for
the stenosis and 7.00% lower than that of the 75° diode. At a higher PVR of 4.0
mmHg/Lpm, the TVG of the 75° diode was 27.3% lower than the TVG of the stenosis
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and 0.830% lower than that of the 60° diode. Clearly both diode designs show significant
reduction in TVG over the stenosis, while both diodes perform quite similarly to each
other.
Similar results were found regarding RF for the diodes and stenosis. Figure 4.16
is the plot of RF vs. PVR for the stenosis and 60° and 75° diodes.
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Figure 4.16: Regurgitant fraction vs. resistance for stenosis, 60° and 75° diodes.
This figure illustrates a marked difference in RF between the stenosis and diodes.
However, the 60° and 75° diodes had fairly similar RF values over most of the range of
PVR. As before, to further quantify the differences between the three devices, a 2nd order
polynomial regression curve was fit to the data sets so that the stenosis and diodes could
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be directly compared to each other at specific values of PVR. The resulting equations and
their corresponding standard error of the fit (sxy) are shown in Table 4.3.
Table 4.3: Regression curve fits for RF (y) vs. PVR (x) data sets
2nd Order Polynomial

Valve

sxy (%)

0.5β Stenosis y = -1.2625x2 + 15.096x + 12.834

0.830

60°α Diode

y = -1.3862x2 + 15.91x + 4.7071

0.744

75°α Diode

y = 1.3373x2 + 1.194x + 22.039

1.212

Table 4.4 gives a direct comparison of the RF at specific PVRs within the tested
range. Values for PVR are listed across the top of the chart, the valve types are listed
along the left side, and the cells in the middle of the table are the corresponding values
for RF with their 95% confidence interval.
Table 4.4: Direct comparison of RF (%) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β Stenosis 32.6±2.58 38.0±2.46 42.7±2.27 46.8±2.09 53.0±2.07
60°α Diode

25.5±2.84 31.0±2.79 35.8±2.53 40.0±2.45 46.2±2.61

75°α Diode

26.8±2.44 29.8±2.82 33.4±2.80 37.7±2.64 48.2±2.76

1

mean ± uncertainty (95%)

From the data in Table 4.4, it is clear that the diodes created a substantially lower
RF than the stenosis. At a low PVR of 1.5 mmHg/Lpm, the RF of the 60° diode was
22.0% lower than the RF of the stenosis and 5.16% lower than that of the 75° diode. At a
PVR of 3.0 mmHg/Lpm, the RF of the 75° diode was 19.5% lower than the RF of the
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stenosis and 5.77% lower than that of the 60° diode. At a higher PVR of 4.0 mmHg/Lpm,
the RF of the 60° diode was 12.9% lower than the RF of the stenosis and 4.24% lower
than that of the 75° diode. Clearly both diode designs show significant reduction in RF
over the stenosis, but performed quite similarly to each other (less than a 5.5% difference
in RF).
Ventricular work as a function of PVR for the stenosis and 60° and 75° diodes
over a normal range of PVR is shown in Figure 4.17.
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Figure 4.17: Ventricular work vs. resistance for the stenosis, 60° and 75° diodes.
The values in Figure 4.17 illustrate a marked difference in ventricular work between the
stenosis and diode. To further quantify the differences between the two devices, a 2nd
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order polynomial regression curve was fit to the data sets so that the stenosis and diode
could be directly compared to each other at specific values of PVR. The resulting
equations, with corresponding standard error of the fit (sxy) are shown in Table 4.5.
Table 4.5: Regression curve fits for Ventricular work (y) vs. PVR (x) data sets
Valve

2nd Order Polynomial

syx (J)

0.5β Stenosis y = 0.0582x2 + 0.1173x + 0.0343 0.0200
60°α Diode

y = 0.0115x2 + 0.2447x - 0.1392

75°α Diode

y = 0.0319x2 + 0.1339x + 0.0008 0.0168

0.0234

Table 4.6 gives a direct comparison of the ventricular work for all of the valve
prototypes at specific PVRs within the tested range. Values for PVR are listed across the
top of the chart, the valve types are listed along the left side, and the cells in the middle of
the table are the corresponding values for work with their 95% confidence interval.
Table 4.6: Direct comparison of Ventricular Work (J) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β
0.341±0.0242 0.502±0.0254 0.691±0.0282 0.910±0.0304 1.44±0.0348
Stenosis
60°α
0.254±0.0253 0.396±0.0259 0.544±0.0274 0.698±0.0289 1.02±0.0315
Diode
75°α
0.273±0.0254 0.396±0.0271 0.535±0.0280 0.690±0.0294 1.05±0.0309
Diode
1
mean ± uncertainty (95%)
From the data in Table 4.6, it is clear that both diode designs required
substantially less ventricular work than the stenosis to achieve the same CO. At a low
PVR of 1.5 mmHg/Lpm, the 60° diode performed better than the stenosis and 75° diode.
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It required 25.6% less work than the stenosis and 7.20% less work than the 75° diode. At
a slightly higher PVR of 2.0 mmHg/Lpm, there was no significant difference in diode
performance, but each showed a 21.0% decrease in work from the stenosis for the same
CO. At a PVR of 3.0 mmHg/Lpm, the 75° diode performed better. It required 24.2% less
work than the stenosis and 1.26% less work than the 60° diode for the same CO. At a
higher PVR of 4.0 mmHg/Lpm, the 60° diode performed better. It required 28.7% less
work than the stenosis and 2.21% less work than the 75° diode for the same CO. Clearly
both diode designs show significant reduction in ventricular work over the stenosis
throughout the entire range of PVR. Interestingly, both diodes performed very similarly
to each other, with neither design standing out as a more efficient design throughout the
range of PVR.

Results for Valve Types Placed in PA
Another set of tests were run to evaluate the performance of the diodes in a
position slightly downstream of the RVOT. In this set of tests, data was collected for all
three of the diode designs, the stenosis, and also an absent valve case (a blank annulus).
Each valve type was placed between the flow probe and the pulmonary artery to simulate
placing it 3 cm within the actual artery rather than in the RVTO and tested over a normal
range of PVR. PVC ranged between 2.38 and 4.39 ml/mmHg, CO was maintained
between 5.00 and 5.20 Lpm, and HR was maintained at 75 bpm.
A qualitative analysis of the work load on the heart for each of the various diodes
and stenosis when placed within the pulmonary artery downstream of the RVOT was

69

accomplished by comparing the PVLs. Several sets of PVLs were obtained for each diode
and the stenosis while the MPCS was set for various physiological conditions. Figures
4.18-20 compare the PVLs of the three diodes to each other and to the stenosis. All of the
PVLs in each figure were obtained under similar system conditions including CO, HR,
and PVR. Since PVR could not be maintained exactly the same for each valve in each
experiment, the figures are presented with the average PVR and its standard deviation for
that set. CO was maintained between 5.0 and 5.2 Lpm, and HR was maintained at 75
bpm.

Figure 4.18: PVLs with a PVR of 1.31±0.03 mmHg/Lpm.
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Figure 4.18 is comprised of PVLs taken with the system operated at a low, normal
PVR. The average PVR for this set of tests is 1.31 mmHg/Lpm with a standard deviation
of 0.03 mmHg/Lpm. The range of PVR in this set is 1.27-1.34 mmHg/Lpm. The shape of
the PVLs in Figure 4.18 differ from those in Figure 4.13 in that there is no isovolumetric
pressure rise at the start of systole. Because the diodes and stenosis allow regurgitant
flow, the PAP is able to fall during diastole and ends up being the same pressure as RVP.
Therefore forward flow is induced as the very start of systole; whereas with a normal
valve the RVP must overcome a higher PAP before forward flow occurs. The shapes of
the PVLs in Figure 4.18 are all similar in shape to each other, but it is clear that the 75°
diode has the smallest loop, and the stenosis has the largest. This indicates that for this set
of tests all of the diodes required less ventricular work than the stenosis, and the 75°
diode was the most efficient.
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Figure 4.19: PVLs with a PVR of 2.66±0.06 mmHg/Lpm.
Figure 4.19 is comprised of PVLs taken with the system operated at a higher,
normal PVR. The average PVR for this set of tests is 2.66 mmHg/Lpm with a standard
deviation of 0.06 mmHg/Lpm. The range of PVR in this set is 2.56-2.69 mmHg/Lpm.
The PVLs in Figure 4.19 are very similar in shape to those in Figure 4.18. However, the
pressures and stroke volumes in Figure 4.19 are much higher and larger. This is to be
expected because the ventricle must work much harder to maintain the same CO through
a more resistive system. As with Figure 4.18, in Figure 4.19, the stenosis produced the
largest PVL, indicating that it is the least efficient. However, unlike Figure 4.18, the
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diode that produced the smallest PVL was the 65° diode, indicating that it is the most
efficient for this test set.

Figure 4.20: PVLs with a PVR of 3.92±0.13 mmHg/Lpm.
Figure 4.20 is comprised of PVLs taken with the system operated at a higher than
normal PVR. The average PVR for this set of tests is 3.92 mmHg/Lpm with a standard
deviation of 0.13 mmHg/Lpm. The range of PVR in this set is 3.84-4.11 mmHg/Lpm. As
with the previous two figures, the 75° diode produced the smallest PVL and the stenosis
produced the largest. And due to the increase in PVR, the pressures in the ventricle and
the stroke volumes increased from the previous test sets. Figure 4.20 clearly illustrates
why the initial ventricle volume was chosen to be 160 ml. The stroke volumes required
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for these tests are so large, if the initial volume smaller, the PVL would indicate a
negative volume in the ventricle towards the end of systole.
Because of the variability of the PVR and CO for the PVLs in Figures 4.18-20, it
is difficult to draw any exact conclusions comparing the efficiency of the diodes based on
these figures alone. However, the general trend throughout the figures indicates that all of
the diodes produce smaller PVLs than the stenosis, and therefore reduce the workload on
the ventricle. A more quantitative analysis between the diodes and stenosis was
conducted based on the areas of these PVLs. The area of a PVL defines the work done by
the ventricle for that heart cycle. This work was found by integrating the product of the
ventricle pressure and downstream flow. Figure 4.21 plots the ventricular work vs. PVR
for all of valve options, including the diodes, stenosis, blank annulus, and SJMB valve.
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Figure 4.21: Ventricular work vs. PVR for stenosis, diodes, SJMB valve and blank
annulus over a range of PVR.
The trends in Figure 4.21 provide a much clearer comparison than individual
PVLs. For lower ranges of normal PVR, all three of the diodes function very similarly,
and they tend to cause the ventricle to work slightly more efficiently than the stenosis.
Interestingly, the blank annulus is more efficient than all of the diodes except when at a
PVR of about 3 mmHg/Lpm.
To facilitate a quantitative analysis, a 2nd order polynomial curve was fit to each
data set in Figure 4.21 using a least-squares regression analysis. The equations are shown
Table 4.7 along with the corresponding standard error of the fit (sxy).
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Table 4.7: Regression curve fits for Work (y) vs. PVR (x) data sets
Valve

2nd Order Polynomial

sxy (J)

0.5β Stenosis

y = 0.0127x2 + 0.399x - 0.2388

0.0337

60°α Diode

y = 0.0156x2 + 0.318x - 0.1508

0.0160

75°α Diode

y = 0.0073x2 + 0.379x - 0.2247

0.0199

90°α Diode

y = -0.0214x2 + 0.5379x - 0.3886

0.0309

SJMB Valve

y = -0.0078x2 + 0.102x - 0.0304

0.00406

Blank Annulus y = -0.0464x2 + 0.7244x - 0.8148

0.0924

Table 4.8 gives a direct comparison of the ventricle workloads for all of the valve
prototypes at specific PVRs within the tested range. Values for PVR are listed across the
top of the chart, the valve types are listed along the left side, and the cells in the middle of
the table are the corresponding values for work with their 95% confidence interval.
Table 4.8: Direct comparison of Ventricular Work (J) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β
0.388±0.0357 0.610±0.037 0.838±0.038 1.073±0.040
1.56±0.042
Stenosis
60°α
0.361±0.0623 0.548±0.063 0.742±0.063 0.945±0.064
1.37±0.066
Diode
75°α
0.360±0.0228 0.563±0.024 0.768±0.026 0.978±0.028
1.41±0.031
Diode
90°α
0.370±0.0331 0.602±0.034 0.822±0.036 0.103±0.037
1.42±0.039
Diode
SJMB
0.105±0.0082 0.142±0.0084 0.176±0.0087 0.205±0.0094 0.253±0.0111
Valve
Blank
0.167±0.0928 0.448±0.0932 0.706±0.0934 0.941±0.0939 1.34±0.0943
Annulus
1
mean ± uncertainty (95%)
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Based on the values in Table 4.8, all three of the diode designs outperform the
stenosis across the entire range of PVR. The 75° diode performs better than the other
diodes for a PVR of 1.5 mmHg/Lpm, but with a PVR of 2.0 mmHg/Lpm and higher, the
60° diode performs best of the three diodes. The 90° diode consistently performs the
worst of the three diodes, although it always outperforms the stenosis. For a low PVR of
1.5 mmHg/Lpm, the 75° diode requires 7.22% less work than the stenosis and 0.30% less
work than the 60° diode. For a PVR of 2.5 mmHg/Lpm, the 60° diode requires 3.48%
less work than the 75° diode and 11.5% less work than the stenosis. For a high PVR of
4.0 mmHg/Lpm, the 60° diode requires 2.65% less work than the 75° diode and 12.2%
less work than the stenosis.
All three of the diodes perform very closely to each other, and better than the
stenosis; although the 75° and 60° diodes consistently performed better than the 90°
diodes. In every case the SJMB valve performed the best, requiring up to 81.6% less
work than the best diode. Interestingly, the blank annulus was significantly more efficient
than all of the diodes over low ranges of PVR, requiring 50.2% less work than the best
diode at a PVR of 1.5 mmHg/Lpm.
It was hypothesized that the PVLs and the comparison of ventricular work
between the three diodes would provide a clear comparison to determine which one
worked best, but the results indicate that the two best diode designs, the 60° and 75°
diodes, perform quite similarly to each other. While the 60° diode performed better than
the 75° diode for all but the lowest values of PVR, the largest difference between the
work loads imposed by the two diodes was only 3.52%.
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The diodes did distinguish themselves from the stenosis and the blank annulus in
this set of tests based on regurgitant fraction (RF). Figure 4.22 plots the RF of each valve
prototype over the same range of PVR.
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Figure 4.22: Regurgitant Fraction vs. PVR for stenosis, diodes, SJMB valve and blank
annulus over a range of PVR.
As seen in Figure 4.22, the diodes clearly produce lower a RF than both the stenosis and
the blank annulus. Because the three diodes had slightly varying cusp geometries to
impede retrograde flow, it was expected that the three diodes would clearly distinguish
themselves from each other based on RF. The diode trends in Figure 4.22 seem to almost
overlay each other, so it is difficult to make any conclusions about RF performance
simply by observing the figure. Therefore, as with the ventricular work data sets, a 2nd
order polynomial curve was fit to each of the data set using the least-squares regression
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method. The resulting equations and their corresponding standard error of the fit (sxy) are
shown in Table 4.9.
Table 4.9: Regression curve fits for RF (y) vs. PVR (x) data sets
Valve

2nd Order Polynomial

syx (%)

0.5β Stenosis

y = -2.0851x2 + 18.904x + 14.968

0.898

60°α Diode

y = -1.6922x2 + 17.038x + 13.08

0.922

75°α Diode

y = -2.0975x2 + 19.324x + 9.8208

0.651

90°α Diode

y = -2.5107x2 + 21.458x + 8.2524

0.530

SJMB Valve

y = -0.4197x2 + 2.6074x + 2.9276

0.647

Blank Annulus

y = -5.0193x2 + 39.393x - 6.502

1.428

Table 4.10 gives a direct comparison of the RF for all of the valve prototypes at
specific PVRs within the tested range. Values for PVR are listed across the top of the
chart, the valve types are listed along the left side, and the cells in the middle of the table
are the corresponding values for RF with their 95% confidence interval.
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Table 4.10: Direct comparison of RF (%) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β Stenosis

38.6±2.20 44.4±2.09 49.2±2.04 52.9±1.92 57.2±1.86

60°α Diode

34.8±2.76 40.4±2.57 45.1±2.46 49.0±2.46 54.2±1.95

75°α Diode

34.1±2.57 40.1±2.46 45.0±2.28 48.9±2.56 53.6±1.86

90°α Diode

34.8±2.62 41.1±2.45 46.2±2.82 50.0±2.31 53.9±2.15

SJMB Valve

5.89±2.81 6.46±2.78 6.82±2.82 6.97±2.77 6.64±2.81

Blank Annulus 41.3±2.32 52.2±2.13 60.6±1.96 66.5±1.83 70.8±1.81
1

mean ± uncertainty (95%)

Based on the values found in Table 4.10, all three diode designs produced a lower
RF than both the stenosis and the blank annulus. Naturally the SJMB valve had the
lowest RF. At the low PVR of 1.5 mmHg/Lpm, the 75° diode performed better than the
other diodes. The RF of the 75° diode was 17.5% lower than that the blank annulus,
11.8% lower than that of the stenosis, and 2.02% lower than that of the next-best diode.
At a PVR of 3.0 mmHg/Lmp, the 60° and 75° diodes had nearly the same RF (within
0.1% difference), which was 26.5% lower than that of the blank annulus, 7.56% lower
than that of the stenosis, and 2.23% lower than that of the 90° diode. At the high PVR of
4.0 mmHg/Lpm, the 75° diode performed better than the other diodes. The RF of the 75°
diode was 24.3% lower than that of the blank annulus, 6.41% lower than that of the
stenosis, and 0.660% lower than that of the next best diode, which for this PVR was the
90° diode. All three of the diodes performed quite similarly to each other in regards to
RF, and no particular design was significantly better than another.
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The comparison of TVG for the diodes, stenosis, blank annulus, and SJMB valve
across a range of PVR is shown in Figure 4.23.
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Figure 4.23: Transvalvular Gradient vs. resistance for stenosis, diodes, SJMB valve and
blank annulus over a range of PVR.
Since all three of the diode designs had the exact same inlet geometry, it was expected
that they all would produce the same TVG. Figure 4.23 clearly indicates that all of the
diodes do indeed produce nearly the same TVG across a range of PVR. Also, as
expected, the blank annulus produced the lowest TVG because there is nothing in the
way to impede antegrade flow. To better quantify the similarities and differences between
the valve types, a 2nd order polynomial curve was fit to the data sets. The resulting
equations and the corresponding standard error of fit (syx) are show in Table 4.11.
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Table 4.11: Regression curve fits for TVG (y) vs. PVR (x) data sets
Valve

2nd Order Polynomial

syx (mmHg)

0.5β Stenosis

y = -2.0701x2 + 28.151x - 15.064

2.131

60°α Diode

y = -1.9894x2 + 26.232x - 12.229

1.070

75°α Diode

y = -2.1813x2 + 27.678x - 13.872

1.200

90°α Diode

y = -3.6042x2 + 35.43x - 22.507

1.589

SJMB Valve

y = 0.1885x2 - 0.2091x + 0.9019

0.153

Blank Annulus

y = -0.509x2 + 5.2086x - 4.8901

0.557

Table 4.12 gives a direct comparison of the TVG for all of the valve prototypes at
specific PVRs within the tested range. Values for PVR are listed across the top of the
chart, the valve types are listed along the left side, and the cells in the middle of the table
are the corresponding values for TVG with their 95% confidence interval.
Table 4.12: Direct comparison of TVG (mmHg) vs. PVR (mmHg/Lpm)1
PVR
1.5

PVR
2.0

PVR
2.5

PVR
3.0

PVR
4.0

0.5β Stenosis

22.5±2.32

33.0±2.32

42.4±2.32

50.8±2.32

64.4±2.32

60°α Diode

22.6±1.40

32.3±1.40

40.9±1.40

48.6±1.41

60. 9±1.41

75°α Diode

22.7±1.50

32.8±1.50

41.7±1.51

49.5±1.51

61.9±1.51

90°α Diode

22.5±1.83

33.9±1.83

43.5±1.83

51.3±1.83

61.5±1.83

SJMB Valve

1.01±0.918 1.24±0.918 1.56±0.918 1.97±0.919 3.08±0.919

Blank Annulus
1

1.78±1.06

3.49±1.06

mean ± uncertainty (95%)
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4.95±1.06

6.16±1.06

7.80±1.06

From Table 4.12, it is clear that all of the diodes performed similarly to each
other, with less than 6.1% difference in TVG over all of the tests. The results that are not
as expected are that the diodes demonstrated no significant improvement in TVG
compared to the stenosis (less than 6% difference throughout the entire range of PVR
tested). In fact, a few of the results indicate the stenosis as having a lower TVG than
some of the diodes. It was expected that the stenosis, which acts simply as an orifice,
would produce a significantly higher TVG than the diodes, which have a nozzle-shaped
inlet, as was the case when the devices were placed in the RVOT. The fact that the diodes
and the stenosis act so similarly during systole for this set of tests indicates that the
performance of the diode is also a function of its placement in the MPCS. Obviously
placing the diode several centimeters downstream of the RVOT greatly reduces the
effectiveness of the diode. It is suspected that for these tests, the short entrance length
between the RVOT and the inlet of the diode altered the flow profile entering the diode,
which reduced the nozzle effect of the diode during systole. Another possible explanation
for the increased TVG with the diode placed in the artery is that although the diode was
moved 3 cm downstream, the catheter used to collect PAP was not moved. As the fluid
enters the nozzle, it experiences a significant pressure drop as the velocity increases. The
pressure rises to the actual PAP as the jet dissipates. If the pressure tap in the catheter is
too close to the diode then the PAP would appear to be lower than it actually is. A lower
PAP would results in a larger TVG.
The results of both sets of tests indicate that the placement of the diode within the
test section greatly affects its performance. Over the range of PVR from 1.5 to 4.0
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mmHg/Lpm, the 60° diode required between 25.7% and 31.9 % less work with it placed
in the RVOT immediately at the contraction of the ventricle than it did with it placed 3
cm downstream. Evidently, to be most effective, the diode must be placed immediately at
the contraction of the ventricle in the MPCS, and be placed in the annulus of the
pulmonary artery in a real pulmonary system.
Overall, the results of this study indicate a higher RF for all of the valve types
than was expected. Camp (2009) reported a much lower RF for the diodes she tested as
well as for a blank annulus. In a benchmark paper, Kilner et al., (2008) reported some
values for RF below 35% for a blank annulus. However, the findings in this study do not
necessarily contradict those found by Kilner et al. Some major differences between the
studies are probable cause for the incongruent results. The values for proximal resistance
used by Kilner et al., were much larger than the proximal resistance in the MPCS of this
study. The proximal resistance in this study’s MPCS (between the pulmonary artery
annulus and the windkessel) was measured as 0.120 mmHg/Lpm through the right branch
and 0.160 mmHg·s/l through the left branch. As these resistances are in parallel, the total
proximal resistance is 0.0690 mmHg/Lpm. Kilner et al., used a resistance of 0.0833
mmHg/Lpm in the main pulmonary artery and a resistance of 0.250 mmHg/Lpm in the
pulmonary artery branches. These two resistances are in series; therefore Kilner’s total
proximal resistance was 0.333 mmHg/Lpm, almost five times larger than that of this
study. As the Kilner et al., model predicts that reducing the resistance upstream of the
compliance elements results in an increased RF, it follows that the MPCS of this study
would produce a larger RF. Also, Kilner et al., kept the stroke volume of their ventricle
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constant, so that as distal resistance was raised, or as proximal resistance was lowered,
the cardiac output was allowed to fall. In this study, the cardiac output was maintained
throughout the entire range of PVR by means of raising stroke volume. With a greatly
increased stroke volume, it follows that the RF would also increase. Several
modifications made to Camp’s MPCS (such as enlarging the hose connections on the
pulmonary artery test section and shortening the length of tubing between the artery and
windkessels) reduced the proximal resistance. Therefore it follows that the RF results in
this study would be greater than those found by Camp.
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CHAPTER FIVE
CONCLUSIONS

The primary objectives of this study were: (1) to conduct a flow visualization with
four diode geometries to evaluate their flow in a pulsatile system, and (2) to evaluate
three diode geometries in vitro in a mock pulmonary circulatory system (MPCS) based
on their ventricular work, regurgitant fraction, and transvalvular gradient.
A two-dimensional test section was developed and built for the purpose of
objective (1). Through flow visualization, all four of the diode designs tested performed
very similarly to each other in both systole and diastole. During systole, each diode
created a strong jet that spanned the entire distance between the two cusps. No vena
contracta was evident during systole for any of the designs. During diastole each diode
created a vena contracta which reduced the effective area of the diode. The diode with
the 75° apex angle reduced the effective flow area the most, from 654 mm2 to 335 mm2, a
48% reduction.
Three diodes, with varying cusp geometries were designed and machined for this
study. A novel pneumatic ventricle was designed and built for this study, and an existing
MPCS was modified to accommodate the new ventricle. Other modifications of the
MPCS were made to improve performance and measurement capabilities, such as the
placement of a flow probes both upstream and downstream of the ventricle. From the
flow and pressure data, PVLs were obtained, and ventricular work, regurgitant fraction
(RF), and transvalvular gradient (TVG) were calculated. These results provided a means
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by which to compare the three diodes to each other as well as to a comparable stenosis
and a blank annulus.
The results of the set of tests in which the devices were placed in the RVOT
indicate that the 60° and 75° diodes perform very similarly to each other based on
ventricular work, RF, and TVG. Neither of the two designs distinguished itself as
significantly better than the other. However, the results indicate that both diodes are a
significant improvement over the 0.5 β stenosis, reducing RF by up to 22.0%, TVG by
up to 27.3%, and ventricular work by up to 28.7%.
The results of the set of tests in which the devices were placed 3 cm downstream
of the RVOT, within the pulmonary artery, indicate that all three of the diodes performed
very similarly to each other in this position as well. None of the diodes significantly
distinguished itself from the others based on any parameter results. However, when
placed in this position, the diodes became significantly less effective than they had been
in the RVOT. The diode with the lowest RF was only an 11.7% improvement over the
stenosis. For some values of PVR, the stenosis actually had a lower TVG than some of
the diodes. The diode that required the least ventricular work was only up to a 13.9%
improvement over the stenosis. Such remarkably different results between the two sets of
test indicate that the placement of the diode in relation to the contraction of the ventricle
greatly affects the diode’s performance.
While placed in the RVOT, the 60° diode produced a RF between 25.5% and
46.2%. Therefore for a patient with a lower PVR, the diode produces an acceptable level
of regurgitation. However, above a PVR of about 2.5 mmHg/Lpm, the RF is higher than
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acceptable. For a PVR of 3.0 mmHg/Lpm the 60° diode produced a TVG of 28.9 mmHg,
which is acceptable. However, at PVRs above that, the TVG is larger and unacceptable.
The results of this study strongly indicate that the placement of the diode greatly
affects its performance, and that the diode must be place at the annulus of the pulmonary
artery to be most effective. The results of the set of tests with the diode placed in the
RVOT suggest that the diode may be a suitable candidate as a replacement for a stenosed
valve providing the patient has a PVR below 2.5 mmHg/Lpm. More research should be
conducted to improve diode design and performance.

Recommendations
Many modifications were made to the MPCS used in this study. While all of the
modifications were beneficial to the system in some way, some modifications also ended
up detracting from the system. Removing the flow probes between the pulmonary artery
branches and the downstream compliance elements helped to reduce the resistance and
inertance in the system; however, removing them also eliminated the ability to accurately
balance the flow between the two artery branches. A recommendation for a system using
a rigid artery test section would be to place a flow probe between each artery branch and
the downstream compliance elements. However, it is also recommended that future
research be conducted with a compliant pulmonary artery test section, as it would be
more physiological. If future research does involve using a compliant artery test section,
the downstream flow probe must again be placed upstream of the test section. One last
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recommendation is to replace the current downstream resistance element with a linear
resistance element, which would be more physiological.
The marked differences in the results between the two sets of testing in the MPCS
indicate that the placement of the diode within the system has as much effect on its
performance as the actual design of the diode. This is an important lesson to be
considered during further research in this area. When placed immediately at the
contraction of the ventricle, the diode affected the flow as it was designed to, and the
result was a significantly lower work load on the ventricle as compared to the stenosis.
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Appendix A
Uncertainty Analysis

Every result of the in vitro testing in this study was extracted from the flow and
pressure measurements taken in the MPCS. Therefore, to quantify the uncertainty of
those results, the uncertainty of the flow and pressure data was determined, and an
uncertainty analysis was performed to determine how those errors propagate into the final
results. Methods described by Figliola and Beasley (2005) were used for the analysis.
Elemental errors for each component were identified, the magnitudes of systematic and
random errors were estimated, and the uncertainty estimate for the results was calculated.
Uncertainty estimates were determined for pulmonary vascular resistance, pulmonary
vascular compliance, transvalvular gradient, regurgitant fraction, and ventricular work.

Sources of Error
Sources of error in the flow and pressure data stem from the following:
calibration, data acquisition, and data reduction. These errors can be either random or
systematic in nature. In a multiple-measurement uncertainty analysis, random errors
within a set of data are accounted for by the random scatter of the data and are given by
the standard uncertainty,

(s )

x k

= s xk

Nk

(A.1)

where sx is the standard deviation of the data, and N is the number of samples taken. For
instance, to determine the random error in a mean flow measurement while analyzing 25
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cycles of data, sx would be the standard deviation of the mean flows for the 25 cycles, and

N would be 25. Random uncertainties are combined using the root-sum-squares method
(RSS). Systematic uncertainties, (bx )k , are combined together using the RSS method. The
total uncertainty at a 95% confidence level is reported as

(

u x = ±t 95 bx2 + s x2

)

1 2

(95%) .

(A.2)

t95 is the weighting function for 95% confidence found as f (ν ,95) from the Student t

distribution where ν is the degrees of freedom, and ν = N-1. In this study, N = 25
because each reported value for pressure and flow was averaged over 25 cycles.

Elemental Errors in Flow and Pressure Measurements
Errors in the upstream flow (Qupstream) and downstream flow (Qdownstream)
measurements are introduced from several elements. Uncertainty in the flow meters’ zero
setting introduces a systematic error whose uncertainty is assigned b1, For both Qupstream
and Qdownstream, b1 = 0.050 Lpm. All random errors originating from the calibration
process are accounted for by the random error of the calibration curve fit, which is
assigned the random uncertainty s1 = s yx based on the standard error of the curve fit (See
Equation A.10). The random error due to variations between cycles in the data set is
assigned the standard random uncertainty s 2 =

s
N

, or the standard deviation of the

mean flow rates. The random uncertainty s1 was found to be 0.061 Lpm and 0.043 Lpm
for Qupstream and Qdownstream respectively. The random uncertainty s2 varied for both

91

Qupstream and Qdownstream between data sets. Table A.1 summarizes the errors in the flow

measurements and their assigned uncertainties.
Table A.1: Errors and uncertainties in all flow measurements
Uncertainty
b1
s1
s2

Assigned uncertainty
Qupstream , Qdownstream
shift in zero point
0.050 Lpm, 0.050 Lpm
calibration/instrument error
0.061 Lpm, 0.043 Lpm
random scatter between cycles of data varies between data sets
Error

Several elemental errors contribute to uncertainties in the pressure measurements.
A systematic error per the manufacturer’s specification is assigned a standard systematic
uncertainty, b1. All random errors originating from the calibration process, including
sensor and instrument resolution, are accounted for by the random error of the calibration
curve fit, which is assigned the random uncertainty s1 = s yx based on the standard error of
the curve fit (See Equation A.10). The random error due to variations between cycles in
the data set is assigned the standard random uncertainty s 2 =

s
N

, or the standard

deviation of the mean pressures. Uncertainty in the pressure transducers’ zero setting
introduces a systematic error whose uncertainties (bRVP and bPAP) for RVP and PAP
respectively were observed to be about 0.200 mmHg. The random uncertainty s1 was
found to be 0.161 mmHg and 0.324 mmHg for RVP and PAP respectively. The random
uncertainty s2 varied for both RVP and PAP between data sets. Table A.2 summarizes the
errors in the flow measurements and their assigned uncertainties.
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Table A.2: Errors and uncertainties in all pressure measurements
Uncertainty
b1
s1
s2

Assigned uncertainty
RVP , PAP
shift in zero point
0.200 mmHg, 0.200 mmHg
calibration/instrument error
0.161 mmHg, 0.324 mmHg
random scatter between cycles of data
varies between data sets
Error

Pulmonary Vascular Resistance
A spectral analysis of the pressure and flow data was used to calculate PVR.
However, it was the zeroth harmonic of the impedance spectrum (Z), which is simply the
average pressure over the average flow, that yields PVR. Therefore the following is used
to analyze error propagation into PVR measurements:

⎞
⎛ ∂Z
⎞ ⎛ ∂Z
= ⎜
u PAP ⎟ + ⎜⎜
u Q ⎟⎟
⎝ ∂PAP
⎠ ⎝ ∂Q ⎠
2

u PVR

where

2

(A.3)

∂Z
PAP
∂Z
1
= − 2 . The uncertainties uPAP and uQ in Equation A.3 are
=
and
∂Q
∂PAP Q
Q

the 95% confidence level uncertainties of PAP and Qdownstream, found by combining the
respective systematic and random uncertainties as shown in Equation A.2. In this study,
the final uncertainties for PVR were typically about ± 0.18 mmHg/Lpm (95%).

Pulmonary Vascular Compliance
The impedance spectrum was also used to determine PVC. However, for
convenience, the uncertainty analysis for PVC was conducted based on the clinical
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method for determining PVC. It is assumed that the spectral method would have even
less uncertainty than the clinical method. Based on the clinical formula for PVC (see
Equation 4.2) the 95% confidence level uncertainty in PVC was determined with
2

u PVC

where

2
2
⎞ ⎛ ∂PVC
⎛ ∂PVC
⎞ ⎛⎜ ∂PVC
⎞
⎟
= ⎜
u CO ⎟ +
u PAPpulse + ⎜
u
⎟ ⎝ ∂HR HR ⎟⎠
⎠ ⎜⎝ ∂PAPpulse
⎝ ∂CO
⎠

(A.4)

− CO ⋅ 1000
∂PVC
− CO ⋅ 1000
∂PVC
∂PVC
1000
=
, and
,
=
.
=
2
∂HR
∂CO
PAPpulse ⋅ HR ∂PAPpulse PAPpulse ⋅ HR
PAPpulse ⋅ CO 2

Heart rate, which was 75.00 bpm in every data set in this study, had negligible
uncertainty; therefore uHR is assigned zero. The uncertainty uCO is found by combining
the systematic uncertainty of Q with the random uncertainty of Qdownstream as in Equation
A.2. In this study, the final uncertainties for PVC were typically about ± 0.18 ml/mmHg
(95%).

Transvalvular Gradient
TVG is determined by
TVG = RVPpeak − PAPpeak .

(A.5)

The 95% confidence level uncertainty for TVG is found by

⎛ ∂TVG
⎞ ⎛ ∂TVG
⎞
= ⎜
u RVP ⎟ + ⎜
u PAP ⎟
⎝ ∂RVP
⎠ ⎝ ∂PAP
⎠
2

uTVG

Where

2

(A.6)

∂TVG
∂TVG
= 1 and
= −1 . The uncertainties uRVP and uPAP are determined by
∂RVP
∂PAP

Equation A.2.
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TVG results reported in Tables 4.2 and 4.12 were determined using a regression
curve fit to the data set. This method introduced a random data-reduction error which is
assigned the random uncertainty s 3 = s yx based on the standard error of the curve fit (See
Equation A.10). This random uncertainty is combined with uTVG using the RSS method.
In this study, the uncertainty in TVG was between ± 1.0 and 1.5 mmHg (95%) when the
devices were placed in the RVOT and between ± 1.0 and 2.5 mmHg (95%) when they
were placed further downstream within the artery.

Regurgitant Fraction
RF is defined as mean reverse flow over mean forward flow (see Equation 3.3);
therefore the uncertainty in RF propagates as the following:

u RF

Where

⎛ ∂RF
= ⎜⎜
u QF
⎝ ∂QF

2

⎞ ⎛ ∂RF
⎟⎟ + ⎜⎜
u QR
⎠ ⎝ ∂QR

⎞
⎟⎟
⎠

2

(A.7)

∂RF − 100 ⋅ QR
∂RF 100
=
. The uncertainties uQF and uQR are determined
=
and
2
∂QF
∂QR QF
QF

by Equation A.2.
RF results reported in Tables 4.4 and 4.10 were determined using a regression
curve fit to the data set. This method introduced a random data-reduction error which is
assigned the random uncertainty s3 = s yx based on the standard error of the curve fit (See
Equation A.10). This random uncertainty is combined with uRF using the RSS method. In
this study, the final uncertainty for RF is typically around ± 2.50% (95%), but always
under ± 3.00% (95%).
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Ventricular Work
Ventricular work was found by integrating the product of RVP and instantaneous
flow into the ventricle over an entire heart cycle. For this uncertainty analysis, it will
suffice to let the ventricular work be found by the following:
n

W = ∑ RVPi ⋅ Qi ⋅ dt

(A.8)

i =1

where n=64 as there was 64 data points taken per heart cycle. dt is 0.0125 s, but has no
known uncertainty in this study. As the uncertainties in RVP and Q are known for any
particular data point, let n=1 and those uncertainties will propagate into the work as
2

2

⎛ ∂W1
⎞ ⎛ ∂W
⎞
uW1 = ⎜⎜
uRVP ⎟⎟ + ⎜⎜ 1 uQ ⎟⎟ .
⎝ ∂RVP1
⎠ ⎝ ∂Q1
⎠

(A.9)

Peak values for RVP and Q are used so that the maximum uncertainty for any time step in
the cycle is determined. This uncertainty is then multiplied by the number of time steps in
a cycle to determine the maximum combined uncertainty, uW.
Ventricular Work results reported in Table 4.6 and 4.8 were determined using a
regression curve fit to the data set. This method introduced a random data-reduction error
which is assigned the random uncertainty s3 = s yx based on the standard error of the curve
fit (See Equation A.10). This random uncertainty is combined with uW using the RSS
method.
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Least-Squares Regression Analysis
A least-squares regression analysis was used to compare RF, TVG, and ventricular work
data for each valve type (See Tables 4.1-4.12). The polyfit function in Matlab was used to
fit a 2nd order polynomial to each data set. The standard error of the fit (syx) was found by
N

s yx =

∑ (y
i =1

i

− y ci )

ν

where ν is the degrees of freedom of the fit.
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2

(A.10)
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